Podcasts about integrative oncology

Host Dr. Nate Pennell and his guest, Dr. Chloe Atreya, discuss the ASCO Educational Book article, “Integrative Oncology: Incorporating Evidence-Based Approaches to Patients With GI Cancers,” highlighting the use of mind-body approaches, exercise, nutrition, acupuncture/acupressure, and natural products. Transcript Dr. Nate Pennell: Welcome to ASCO Education: By the Book, our new monthly podcast series that will feature engaging discussions between editors and authors from the ASCO Educational Book. We'll be bringing you compelling insights on key topics featured in Education Sessions at ASCO meetings and some deep dives on the approaches shaping modern oncology.  I'm Dr. Nate Pennell, director of the Cleveland Clinic Lung Cancer Medical Oncology Program as well as vice chair of clinical research for the Taussig Cancer Institute. Today, I'm delighted to welcome Dr. Chloe Atreya, a professor of Medicine in the GI Oncology Group at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, and the UCSF Osher Center for Integrative Health, to discuss her article titled, “Integrative Oncology Incorporating Evidence-Based Approaches to Patients With GI Cancers”, which was recently published in the ASCO Educational Book. Our full disclosures are available in the transcript of this episode.  Dr. Atreya, it's great to have you on the podcast today. Thanks for joining me. Dr. Chloe Atreya: Thanks Dr. Pennell. It's a pleasure to be here. Dr. Nate Pennell: Dr. Atreya, you co-direct the UCSF Integrative Oncology Program with a goal to really help patients with cancer live as well as possible. And before we dive into the review article and guidelines, I'd love to just know a little bit about what inspired you to go into this field? Dr. Chloe Atreya: Yeah, thank you for asking. I've had a long-standing interest in different approaches to medicine from global traditions and I have a degree in pharmacology, and I continue to work on new drug therapies for patients with colorectal cancer. And one thing that I found is that developing new drugs is a long-term process and often we're not able to get the drugs to the patients in front of us. And so early on as a new faculty member at UCSF, I was trying to figure out what I could do for the patient in front of me if those new drug therapies may not be available in their lifetime. And one thing I recognized was that in some conversations the patient and their family members, even if the patient had metastatic disease, they were able to stay very present and to live well without being sidelined by what might happen in the future. And then in other encounters, people were so afraid of what might be happening in the future, or they may have regrets maybe about not getting that colonoscopy and that was eroding their ability to live well in the present.  So, I started asking the patients and family members who were able to stay present, “What's your secret? How do you do this?” And people would tell me, “It's my meditation practice,” or “It's my yoga practice.” And so, I became interested in this. And an entry point for me, and an entry point to the Osher Center at UCSF was that I took the Mindfulness-Based Stress Reduction Program to try to understand experientially the evidence for this and became very interested in it. I never thought I would be facilitating meditation for patients, but it became a growing interest. And as people are living longer with cancer and are being diagnosed at younger ages, often with young families, how one lives with cancer is becoming increasingly important.   Dr. Nate Pennell: I've always been very aware that it seemed like the patients that I treated who had the best quality of life during their life with cancer, however that ended up going, were those who were able to sort of compartmentalize it, where, when it was time to focus on discussing treatment or their scans, they were, you know, of course, had anxiety and other things that went along with that. But when they weren't in that, they were able to go back to their lives and kind of not think about cancer all the time. Whereas other people sort of adopt that as their identity almost is that they are living with cancer and that kind of consumes all of their time in between visits and really impacts how they're able to enjoy the rest of their lives. And so, I was really interested when I was reading your paper about how mindfulness seemed to be sort of like a formal way to help patients achieve that split. I'm really happy that we're able to talk about that. Dr. Chloe Atreya: Yeah, I think that's absolutely right. So, each of our patients is more than their cancer diagnosis. And the other thing I would say is that sometimes patients can use the cancer diagnosis to get to, “What is it that I really care about in life?” And that can actually heighten an experience of appreciation for the small things in life, appreciation for the people that they love, and that can have an impact beyond their lifetime. Dr. Nate Pennell: Just in general, I feel like integrative medicine has come a long way, especially over the last decade or so. So, there's now mature data supporting the incorporation of elements of integrative oncology into comprehensive cancer care. We've got collaborations with ASCO. They've published clinical practice guidelines around diet, around exercise, and around the use of cannabinoids. ASCO has worked with the Society for Integrative Oncology to address management of pain, anxiety, depression, fatigue – lots of different evidence bases now to try to help guide people, because this is certainly something our patients are incredibly interested in learning about. Can you get our listeners up to speed a little bit on the updated guidelines and resources supporting integrative oncology? Dr. Chloe Atreya: Sure. I can give a summary of some of the key findings. And these are rigorous guidelines that came together by consensus from expert panels. I had the honor of serving on the anxiety and depression panel. So, these panels will rate the quality of the evidence available to come up with a strength of recommendation. I think that people are at least superficially aware of the importance of diet and physical activity and that cannabis and cannabinoids have evidence of benefit for nausea and vomiting. They may not be aware of some of the evidence supporting these other modalities. So, for anxiety and depression, mindfulness-based interventions, which include meditation and meditative movement, have the strongest level of evidence. And the clinical practice guidelines indicate that they should be offered to any adult patient during or after treatment who is experiencing symptoms of anxiety or depression. Other modalities that can help with anxiety and depression include yoga and Tai Chi or Qigong. And with the fatigue guidelines, mindfulness-based interventions are also strongly recommended, along with exercise and cognitive behavioral therapy, Tai Chi and Qigong during treatment, yoga after treatment.  And some of these recommendations also will depend on where the evidence is. So, yoga is an example of an intervention that I think can be helpful during treatment, but most of our evidence is on patients who are post-treatment. So, most of our guidelines separate out during treatment and the post-treatment phase because the quality of evidence may be different for these different phases of treatment.  With the pain guidelines, the strongest recommendation is for acupuncture, specifically for people with breast cancer who may be experiencing joint pain related to aromatase inhibitors. However, acupuncture and other therapies, including massage, can be helpful with pain as well. So those are a few of the highlights. Dr. Nate Pennell: Yeah, I was surprised at the really good level of evidence for the mindfulness-based practices because I don't think that's the first thing that jumps to mind when I think about integrative oncology. I tend to think more about physical interventions like acupuncture or supplements or whatnot. So, I think this is really fantastic that we're highlighting this.  And a lot of these interventions like the Qigong, Tai Chi, yoga, is it the physical practice of those that benefits them or is it that it gives them something to focus on, to be mindful of? Is that the most important intervention? It doesn't really matter what you're doing as long as you have something that kind of takes you out of your experience and allows you to focus on the moment. Dr. Chloe Atreya: I do think it is a mind, body and spirit integration, so that all aspects are important. We also say that the best practice is the one that you actually practice. So, part of the reason that it's important to have these different modalities is that not everybody is going to take up meditation. And there may be people for whom stationary meditation, sitting and meditating, works well, and other people for whom meditative movement practices may be what they gravitate to. And so, I think that it's important to have a variety of options. And one thing that's distinct from some of our pharmacologic therapies is that the safety of these is, you know, quite good. So, it becomes less important to say, “Overall, is Tai Chi better or is yoga better?” for instance. It really depends on what it is that someone is going to take up. Dr. Nate Pennell: And of course, something that's been really nice evidence-based for a long time, even back when I was in my training in the 2000s with Jennifer Temel at Massachusetts General Hospital, was the impact of physical activity and exercise on patients with cancer. It seems like that is pretty much a universally good recommendation for patients. Dr. Chloe Atreya: Yes, that's absolutely right. Physical activity has been associated with improved survival after a cancer diagnosis. And that's both cancer specific survival and overall survival.  The other thing I'll say about physical activity, especially the mindful movement practices like Tai Chi and Qigong and yoga, is that they induce physiologic shifts in the body that can promote relaxation, so they can dampen that stress response in a physiologic way. And these movement practices are also the best way to reduce cancer-associated fatigue. Dr. Nate Pennell: One of the things that patients are always very curious about when they talk to me, and I never really feel like I'm as well qualified as I'd like to be to advise them around dietary changes in nutrition. And can you take me a little bit through some of the evidence base for what works and what doesn't work? Dr. Chloe Atreya: Sure. I do think that it needs to be tailored to the patient's needs. Overall, a diet that is plant-based and includes whole grains is really important. And I often tell patients to eat the rainbow because all of those different phytochemicals that cause the different colors in our fruits and vegetables are supporting different gut microbiota. So that is a basis for a healthy gut microbiome. That said, you know, if someone is experiencing symptoms related to cancer or cancer therapy, it is important to tailor dietary approaches. This is where some of the mindful eating practices can help. So, sometimes actually not just focusing on what we eat, but how we eat can help with symptoms that are associated with eating. So, some of our patients have loss of appetite, and shifting one's relationship to food can help with nutrition. Sometimes ‘slow it down' practices can help both with appetite and with digestion. Dr. Nate Pennell: One of the things that you said both in the paper and just now on our podcast, talking about how individualized and personalized this is. And I really liked the emphasis that you had on flexibility and self-compassion over rigid discipline and prescriptive recommendations here. And this is perhaps one of the real benefits of having an integrative oncology team that can work with patients as opposed to them just trying to find things online. Dr. Chloe Atreya: Yes, particularly during treatment, I think that's really important. And that was borne out by our early studies we called “Being Present.” So, after I was observing the benefits anecdotally among my patients of the ability to be present, we designed these pilot studies to teach meditation and meditative practices to patients. And in these pilot studies, the original ones were pretty prescriptive in a way that mindfulness-based stress reduction is fairly prescriptive in terms of like, “This is what we're asking you to do. Just stick with the program.” And there can be benefits if you can stick with the program. It's really hard though if someone is going through treatment and with GI cancers, it may be that they're getting chemotherapy every two weeks and they have one week where they're feeling really crummy and another week where they're trying to get things done. And we realized that sometimes people were getting overwhelmed and feeling like the mindfulness practice was another thing on their to-do list and that they were failing if they didn't do this thing that was important for them. And so, we've really kind of changed our emphasis. And part of our emphasis now is on incorporating mindfulness practices into daily life. Any activity that doesn't require a lot of executive function can be done mindfully, meaning with full attention. And so, especially for some of our very busy patients, that can be a way of, again, shifting how I'm doing things rather than adding a new thing to do. Dr. Nate Pennell: And then another part I know that patients are always very curious about that I'm really happy to see that we're starting to build an evidence base for is the use of supplements and natural products. So, can you take us a little bit through where we stand in terms of evidence behind, say, cannabis and some of the other available products out there? Dr. Chloe Atreya: Yeah, I would say that is an area that requires a lot more study. It's pretty complicated because unlike mindfulness practices where there are few interactions with other treatments, there is the potential for interactions, particularly with the supplements. And the quality of the supplements matters. And then there tends to be a lot of heterogeneity among the studies both in the patients and what other treatments they may be receiving, as well as the doses of the supplements that they're receiving.  One of my earliest mentors at Yale is someone named Dr. Tommy Chang, who has applied the same rigor that that we apply to testing of biomedical compounds to traditional Chinese medicine formulas. And so, ensuring that the formulation is stable and then formally testing these formulations along with chemotherapy. And we need more funding for that type of research in order to really elevate our knowledge of these natural products. We often will direct patients to the Memorial Sloan Kettering ‘About Herbs, Botanicals, and Other Products' database as one accessible source to learn more about the supplements. We also work with our pharmacists who can provide the data that exists, but we do need to take it with a grain of salt because of the heterogeneity in the data. And then it's really important if people are going to take supplements, for them to take supplements that are of high quality. And that's something in the article that we list all of the things that one should look for on the label of a supplement to ensure that it is what it's billed to be. Dr. Nate Pennell: So, most of what we've been talking about so far has really been applying to all patients with cancer, but you of course are a GI medical oncologist, and this is a publication in the Educational Book from the ASCO GI Symposium. GI cancers obviously have an incredibly high and rising incidence rate among people under 50, representing a quarter of all cancer incidence worldwide, a third of cancer related deaths worldwide. Is there something specific that GI oncologists and patients with GI cancers can take home from your paper or is this applicable to pretty much everyone? Dr. Chloe Atreya: Yeah, so the evidence that we review is specifically for GI cancers. So, it shows both its strengths and also some of the limitations. So many of the studies have focused on other cancers, especially breast cancer. In the integrative oncology field, there are definitely gaps in studying GI cancers. At the same time, I would say that GI cancers are very much linked to lifestyle in ways that are complicated, and we don't fully understand. However, the best ways that we can protect against development of GI cancers, acknowledging that no one is to blame for developing a GI cancer and no one is fully protected, but the best things that we can do for overall health and to prevent GI cancers are a diet that is plant-based, has whole grains. There's some data about fish that especially the deep-water fish, may be protective and then engaging in physical activity.  One thing I would like for people to take away is that these things that we know that are preventative against developing cancer are also important after development of a GI cancer. Most of the data comes from studies of patients with colorectal cancer and that again, both cancer specific and overall mortality is improved with better diet and with physical activity. So, this is even after a cancer diagnosis. And I also think that, and this is hard to really prove, but we're in a pretty inflammatory environment right now. So, the things that we can do to decrease stress, improve sleep, decrease inflammation in the body, and we do know that inflammation is a risk factor for developing GI cancers. So, I think that all of the integrative modalities are important both for prevention and after diagnosis. Dr. Nate Pennell: And one of the things you just mentioned is that most of the studies looking at integrative oncology and GI cancers have focused on colorectal cancer, which of course, is the most common GI cancer. But you also have pointed out that there are gaps in research and what's going on and what needs to be done in order to broaden some of this experience to other GI cancers. Dr. Chloe Atreya: Yeah, and I will say that there are gaps even for colorectal cancer. So right now, some of the authors on the article are collaborating on a textbook chapter for the Society for Integrative Oncology. And so, we're again examining the evidence specifically for colorectal cancer and are in agreement that the level of evidence specific to colorectal cancer is not as high as it is for all patients with adult cancers. And so even colorectal cancer we need to study more.  Just as there are different phases of cancer where treatments may need to be tailored, we also may need to tailor our treatments for different cancer types. And that includes what symptoms the patients are commonly experiencing and how intense the treatment is, and also the duration of treatment. Those are factors that can influence which modalities may be most important or most applicable to a given individual. Dr. Nate Pennell: So, a lot of this sounds fantastic. It sounds like things that a lot of patients would really appreciate working into their care. Your article focused a little bit on some of the logistics of providing this type of care, including group medical visits, multidisciplinary clinics staffed by multiple types of clinicians, including APPs and psychologists, and talked about the sustainability of this in terms of increasing the uptake of guideline-based integrative oncology. Talk a little bit more about both at your institution, I guess, and the overall health system and how this might be both sustainable and perhaps how we broaden this out to patients outside of places like UCSF. Dr. Chloe Atreya: Yes, that's a major focus of our research effort. A lot of comprehensive cancer centers and other places where patients are receiving care, people may have access to dietitians, which is really important and nutritionists. In the article we also provide resources for working with exercise therapists and those are people who may be working remotely and can help people, for instance, who may be in, in rural areas. And then our focus with the mind-body practices in particular has been on group medical visits. And this grew out of, again, my ‘being present' pilot studies where we were showing some benefit. But then when the grant ends, there isn't a way to continue to deliver this care. And so, we were asking ourselves, you know, is there a way to make this sustainable? And group medical visits have been used in other settings, and they've been working really well at our institution and other institutions are now taking them up as well. And this is a way that in this case it's me and many of my colleagues who are delivering these, where I can see eight or ten patients at once. In my case, it's a series of four two-hour sessions delivered by telehealth. So, we're able to focus on the integrative practices in a way that's experiential. So, in the clinic I may be able to mention, you know, after we go over the CT scans, after we go over the labs and the molecular profiling, you know, may be able to say, “Hey, you know, meditation may be helpful for your anxiety,” but in the group medical visits we can actually practice meditation, we can practice chair yoga. And that's where people have that experience in their bodies of these different modalities. And the feedback that we're receiving is that that sticks much more to experience it then you have resources to continue it. And then the group is helpful both in terms of delivery, so timely and efficient care for patients. It's also building community and reducing the social isolation that many of our patients undergoing treatment for cancer experience. Dr. Nate Pennell: I think that makes perfect sense, and I'm glad you brought up telehealth as an option. I don't know how many trained integrative oncologists there are out there, but I'm going to guess this is not a huge number out there. And much like other specialties that really can improve patients' quality of life, like palliative medicine, for example, not everyone has access to a trained expert in their cancer center, and things like telemedicine and telehealth can really potentially broaden that. How do you think telehealth could help broaden the exposure of cancer patients and even practitioners of oncology to integrative medicine? Dr. Chloe Atreya: Yes, I think that telehealth is crucial for all patients with cancer to be able to receive comprehensive cancer care, no matter where they're receiving their chemotherapy or other cancer-directed treatments. So, we will routinely be including patients who live outside of San Francisco. Most of our patients live outside of San Francisco. There's no way that they could participate if they had to drive into the city again to access this. And in the group setting, it's not even safe for people who are receiving chemotherapy to meet in a group most times. And with symptoms, often people aren't feeling so well and they're able to join us on Zoom in a way that they wouldn't be able to make the visit if it was in person. And so, this has really allowed us to expand our catchment area and to include patients, in our case, in all of California. You also mentioned training, and that's also important. So, as someone who's involved in the [UCSF] Osher Collaborative, there are faculty scholars who are at universities all over the US, so I've been able to start training some of those physicians to deliver group medical visits at their sites as well via telehealth. Dr. Nate Pennell: I'm glad we were able to make a plug for that. We need our political leadership to continue to support reimbursement for telehealth because it really does bring access to so many important elements of health care to patients who really struggle to travel to tertiary care centers. And their local cancer center can be quite a distance away.  So, sticking to the theme of training, clinician education and resources are really crucial to continue to support the uptake of integrative oncology in comprehensive cancer care. Where do you think things stand today in terms of clinician education and professional development in integrative oncology. Dr. Chloe Atreya: It's growing. Our medical students now are receiving training in integrative medicine, and making a plug for the Educational Book, I was really happy that ASCO let us have a table that's full of hyperlinks. So that's not typical for an article. Usually, you have to go to the reference list, but I really wanted to make it practical and accessible to people, both the resources that can be shared with patients that are curated and selected that we thought were of high-quality examples for patients. At the bottom of that table also are training resources for clinicians, and some of those include: The Center for Mind-Body Medicine, where people can receive training in how to teach these mind-body practices; The Integrated Center for Group Medical Visits, where people can learn how to develop their own group medical visits; of course, there's the Society for Integrative Oncology; and then I had just mentioned the Osher Collaborative Faculty Fellowship. Dr. Nate Pennell: Oh, that is fantastic. And just looking through, I mean, this article is really a fantastic resource both of the evidence base behind all of the elements that we've discussed today. Actually, the table that you mentioned with all of the direct hyperlinks to the resources is fantastic. Even recommendations for specific dietary changes after GI cancer diagnosis. So, I highly recommend everyone read the full paper after they have listened to the podcast today.  Before we wrap up, is there anything that we didn't get a chance to discuss that you wanted to make sure our listeners are aware of? Dr. Chloe Atreya: One thing that I did want to bring up is the disparities that exist in access to high quality symptom management care. So, patients who are racial and ethnic minorities, particularly our black and Latinx patients, the evidence shows that they aren't receiving the same degree of symptom management care as non-Hispanic White patients. And that is part of what may be leading to some of the disparities in cancer outcomes. So, if symptoms are poorly managed, it's harder for patients to stay with the treatment, and integrative oncology is one way to try to, especially with telehealth, this is a way to try to improve symptom management for all of our patients to help improve both their quality of life and their cancer outcomes. Dr. Nate Pennell: Well, Dr. Atreya, it's been great speaking with you today and thank you for joining me on the ASCO Education: By the Book Podcast and thank you for all of your work in advancing integrative oncology for GI cancers and beyond. Dr. Chloe Atreya: Thank you, Dr. Pennell. It's been a pleasure speaking with you. Dr. Nate Pennell: And thank you to all of our listeners who joined us today. You'll find a link to the article discussed today in the transcript of the episode. We hope you'll join us again for more insightful views on topics you'll be hearing at the Education Sessions from ASCO meetings throughout the year and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate, educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:    Dr. Nathan Pennell   @n8pennell  @n8pennell.bsky.social  Dr. Chloe Atreya  Follow ASCO on social media:    @ASCO on X (formerly Twitter)    ASCO on Bluesky   ASCO on Facebook    ASCO on LinkedIn    Disclosures:   Dr. Nate Pennell:       Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron      Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi   Dr. Chloe Atreya: Consulting or Advisory Role: Roche Genentech, Agenus Research Funding (Institution): Novartis, Merck, Bristol-Myers Squibb, Guardant Health, Gossamer Bio, Erasca, Inc.

Kara Kenan is the founder & CEO of the Cancer Wellness Institute, where she trains and certifies cancer coaches globally. A passionate advocate for cancer survivorship, Kara has developed evidence-based programs that empower patients, survivors, and health professionals. She also serves as the Executive Director for Going Beyond the Pink, a North Carolina-based breast cancer support nonprofit, and Marketing & Communications Manager at the National Coalition for Cancer Survivorship (NCCS). Kara is actively involved in cancer policy and advocacy with NCCS and the Society for Integrative Oncology, and has been a treatment guideline reviewer with American Society for Clinical Oncology (ASCO). Leveraging AI, she has scaled her online courses, enhancing accessibility and support for cancer coaches worldwide. With over a decade of experience in coaching, advocacy, and curriculum development, Kara is dedicated to bridging gaps in survivorship care through education, innovation, and policy work.

Download Your Free Ultimate Guide to Water Fasting to Heal Cancer and Chronic Illness  https://www.katiedeming.com/prolonged-water-fasting/What could lead a respected radiation oncologist to walk away from traditional medicine?In this bonus episode, Dr. Katie Deming appears on "Conversations with Dr. Cowan and Friends" podcast. Dr. Cowan explores Dr. Deming's remarkable journey from treating cancer with radiation to helping clients heal through a whole-person approach addressing physical, emotional, mental, and spiritual aspects of wellness.Dr. Deming shares her unique path—from her early athletic career as a springboard diver and professional triathlete who trained at the Olympic Training Center, to her profound experiences helping patients transition through medical aid in dying, to her own spiritual awakening that fundamentally changed her understanding of healing.Chapters:13:29 – Internal conflict and the decision to leave oncology17:59 – A shared death experience that changed her perspective32:00 – Discovering and working with a powerful shamanic mentor42:21 – Launching a virtual integrative cancer healing practice52:00 – Reflections on death, fragmentation of the soul, and spiritual alignmentHer perspective bridges Western medicine and alternative healing modalities, offering insights into what she believes truly causes cancer—from mitochondrial dysfunction and toxicity to unprocessed emotions and subconscious programming.Listen and learn how addressing root causes rather than symptoms can lead to profound transformation, and why creating peace within the body might be the most important first step toward wellness.Connect with Dr. Tom Cowan: https://drtomcowan.com/Send us a text with your question (include your phone number)MORE FROM KATIE DEMING M.D. Download Your Free Ultimate Guide to Water Fasting to Heal Cancer and Chronic Illness https://www.katiedeming.com/prolonged-water-fasting/6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollWork with Dr. Katie: www.katiedeming.comFollow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/ Take a Deeper Dive into Your Healing Journey: Dr. Katie Deming's Linkedin Here Please Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast DISCLAIMER:The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, c...

In this episode of The Moss Report, Ben Moss and Dr. Ralph W. Moss explore the science and tradition behind ginger's role in cancer prevention and care. From leukemia stem cells to chemotherapy-induced nausea, ginger shows remarkable promise backed by real-world use and peer-reviewed research. Learn how to use roasted ginger powder, what sets ginger apart from turmeric, and why Dr. Moss believes it's a cornerstone of integrative cancer support. Products Mentioned Great Value Organic Turmeric Powder: https://amzn.to/4hZLT8K Frontier Organic Ginger Powder:  https://amzn.to/42rZsJE Garden of Life Golden Milk Powder: https://amzn.to/4ce9elW Gaia Herbs Golden Milk: https://amzn.to/42jSYvb Consumerlab Review of Ginger Products: https://www.consumerlab.com/reviews/ginger-supplement-review/ginger/?search=Ginger About Prof. Tsvee Lapidot https://bioforumconf.com/6th-international-meeting-of-the-israel-stem-cell-/820-prof-tsvee-lapidot About John Dick, PhD https://www.cdnmedhall.ca/laureates/johndick Important Links “A comprehensive self-help plan for cancer includes medicinal mushrooms. They are indispensable”. – Ralph W. Moss, PhD The Moss Method Mushroom Formula → https://mycolife.us For more information on cancer-fighting foods and supplements, please visit our website: https://www.themossreport.com Get The Moss Method Book →  https://www.amazon.com/gp/product/1881025799/ Moss Report Treatment Guides → https://themossreport.store/guides Dr. Moss' library of previous books → https://themossreport.store/books/ Explore Townsend Letter → https://www.townsendletter.com The deep dive 'Clinic Conversations' between Dr. Moss and Integrative Oncologists from around the world are available at → https://themossreport.com/doctors-clinics The Center for Integrative Oncology - https://www.intonc.org - is dedicated to exploring cancer care worldwide, bringing you in-depth reporting and insights through The Moss Report. As a 501(c)(3) nonprofit, the CIO relies on public support to continue this vital work. Please consider making a donation to help uncover and share current approaches and resources in cancer treatment. Cited Resources • Chueahongthong F, Tima S, Chiampanichayakul S, et al. Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells. Molecules. 2021 Sep 24;26(19):5785. doi: 10.3390/molecules26195785. PMID: 34641328; PMCID: PMC8510311. https://pubmed.ncbi.nlm.nih.gov/34641328 • Crichton M, Marshall S, Isenring E, et al. Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial. J Acad Nutr Diet. 2024 Mar;124(3):313-330.e6. doi: 10.1016/j.jand.2023.09.003. Epub 2023 Sep 10. PMID: 37699474. https://pubmed.ncbi.nlm.nih.gov/37699474 • Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994 Feb 17;367(6464):645-8. doi: 10.1038/367645a0. PMID: 7509044. https://pubmed.ncbi.nlm.nih.gov/7509044 • Panyajai P, Viriyaadhammaa N, Chiampanichayakul S, et al. Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells. BMC Complement Med Ther. 2025 Feb 28;25(1):87. doi: 10.1186/s12906-025-04829-7. PMID: 40022126; PMCID: PMC11869560. https://pubmed.ncbi.nlm.nih.gov/40022126 • Shidfar F, Rajab A, Rahideh T, et al. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J Complement Integr Med. 2015 Jun;12(2):165-70. doi: 10.1515/jcim-2014-0021. PMID: 25719344. https://pubmed.ncbi.nlm.nih.gov/25719344

In this episode of Integrative Oncology Talk, host Judith Lacey welcomes Dr. Santhosshi Narayanan from MD Anderson to discuss Ayurvedic medicine's potential benefits for cancer patients. Narayan, an internal medicine physician specializing in integrative oncology, delves into the ancient practices of Ayurveda, which emphasizes a personalized approach incorporating diet, exercise, and mind-body techniques. The conversation covers Ayurveda's principles, how it can complement conventional cancer care, and the importance of studying Ayurvedic herbs for safety and efficacy. The episode also discusses the significance of collaboration between conventional and Ayurvedic practitioners to provide comprehensive, patient-tailored cancer care.

What if everything we thought we knew about cancer was wrong? For decades, scientists have debated what really causes cancer. Is it genetic mutations, as the Somatic Mutation Theory suggests? Is it a metabolic dysfunction, as the Metabolic Theory argues? Or is there a deeper, overlooked truth—one that could redefine cancer treatment as we know it? In this episode, Dr. Ralph Moss and Ben Moss break down the battle between competing cancer theories, why conventional wisdom is being challenged, and what the latest research is uncovering about cancer stem cells, metabolism, and the Warburg Effect.

Robin Daly speaks at the 2025 Public Forum on Healing with Integrative Cancer Care in February. The gathering was designed to bridges wisdom traditions with emerging frontiers in healing. This year's forum explores transformation through the intersections of integrative cancer care with consciousness and healing arts, featuring distinguished speakers and practitioners from diverse backgrounds. The day included engaging presentations on patient advocacy, expressive arts, and innovative approaches to cancer care. Robin Daly is Chairman & Founder of Yes to Life, a UK Registered Charity. Robin has no training or background in healthcare, but was plunged into the arena in 1990 when his youngest daughter Bryony was diagnosed with cancer, aged 9. She went on to be re-diagnosed twice with treatment-related cancers, eventually dying at 23. The immense difficulties the family faced introducing treatment choices that reflected their own understanding of health and wellbeing prompted him to set up Yes to Life in 2004 to help others in similar situations, and to advocate on behalf of patients for what is now called Integrative Oncology. Yes to Life is now celebrating its 20th Anniversary having helped many thousands with cancer with a wide range of supportive resources, and continues to play a key role in changing the discussion around cancer care. The New School at Commonweal is a collaborative learning community offering conversations about nature, culture, and inner life---so that we can all find meaning, meet inspiring people, and explore the beauty and grief of our changing world. Please like/follow our YouTube channel for more great podcasts. Find out more about The New School at Commonweal on our website: tns.commonweal.org. And like/follow our Soundcloud channel for more great podcasts.

Download Your Free Guide - 3 Things You Need to Know About Cancer:  https://www.katiedeming.com/cancer-101/Is the entire American healthcare system designed to keep you sick instead of making you well?Dr. Katie Deming, a former radiation oncologist with 20 years of experience treating cancer patients, shares her unique perspective on Robert F. Kennedy Jr.'s recent confirmation as Secretary of Health and Human Services. With healthcare costs soaring to $4.5 trillion annually while Americans get sicker and life expectancy decreases, Dr. Deming explores why this is happening and what needs to change. Key Takeaways:• The Make America Healthy Again Commission• Why cancer rates have increased• The toxins in our food and water supply affecting your health• Why many effective natural treatments remain unknown to most doctors• The role of microplastics and EMFs in chronic diseaseDr. Katie  breaks down the stark reality of our current health crisis - from rising cancer rates in young people to the explosion of chronic diseases - and explains why having leadership willing to ask tough questions and examine real scientific data matters for your health.Listen and learn about promising changes that could reshape how we approach health in America.Send us a text with your question (include your phone number)Watch & Listen to Born to Heal on Youtube: Click Here Don't Face Cancer Alone"The 6 Pillars of Healing Cancer" workshop series provides you valuable insights and strategies to support your healing journey - Click Here to Enroll MORE FROM KATIE DEMING M.D. Free Guide - 3 Things You Need to Know About Cancer: https://www.katiedeming.com/cancer-101/6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollWork with Dr. Katie: www.katiedeming.comFollow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/ Take a Deeper Dive into Your Healing Journey: Dr. Katie Deming's Linkedin Here Please Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast DISCLAIMER:The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare p...

TRIGGER WARNING: This episode discusses themes and personal experiences involving suicide. If this is triggering to you, please proceed to listen to this episode with caution or skip this one. If you or someone you know is experiencing suicidal thoughts or a crisis, 988 offers 24/7 judgment-free support for mental health, substance use, and more. Text, call, or chat 988.Today, I'm thrilled to have a truly inspiring guest with me, Dr. Nasha Winters. Dr. Winters is a metabolic health specialist, integrative oncology pioneer, and the mind behind the groundbreaking works 'The Metabolic Approach to Cancer' and 'Mistletoe and the Future of Integrative Oncology'. In this episode, Dr. Winters shares her remarkable story of being diagnosed with end-stage cancer at the age of 19 and shattering all medical expectations to become a thriving survivor and a beacon of hope for many who are also struggling with cancer and other chronic diseases. I also share about my mom's recent cancer diagnosis and recovery journey and how, through that, I discovered the work of Dr. Winters and was inspired by her Terrain 10 approach to cancer recovery. I'm so excited I got to go deep with her about why cancer is on the rise globally and what we can do to better support ourselves — because prevention is the best cure for cancer. Whether you're battling cancer or looking to prevent it, I hope this episode inspires you to check out Dr. Winters' work and take control of your health journey. Get ready for an incredible discussion that could change your entire view on cancer. Disclaimer: This information is being provided to you for educational and informational purposes only. It is being provided to educate you about how to take care of your body and as a self-help tool for your own use so that you can reach your own health goals. It is not intended to treat or cure any specific illness and is not to replace the guidance provided by your own medical practitioner. If you are under the care of a healthcare professional or currently use prescription medications, you should discuss any dietary changes or potential dietary supplement use with your doctor, and should not discontinue any prescription medications without first consulting your doctor. This information is to be used at your own risk based on your own judgment. If you suspect you have a medical problem, we urge you to take appropriate action by seeking medical attention.Find more from Dr. Winters online: Website: https://www.drnasha.com/The Metabolic Approach to CancerPodcast: https://www.drnasha.com/metabolic-mattersDr. Winters' Research: https://www.mtih.org/Link to Huberman Labs episode: https://www.youtube.com/watch?v=xjEFo3a1AnI&ab_channel=AndrewHubermanConnect with Sophie: Instagram: @shetalkshealthWebsite:

Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg. I'm a medical oncologist and an adjunct associate professor at UT Southwestern Medical Center in Dallas. Today, we're bringing you some key highlights from the 2025 ASCO Gastrointestinal Cancers Symposium, and I'm delighted to be joined by the chair of GI25, Dr. David Wang. Dr. Wang is a GI medical oncologist at the University of Michigan. Our full disclosures are available in the transcript of this episode.  Dr. Wang, thanks for coming on the podcast today. Dr. David Wang: Well, thank you. It's a pleasure to be here. Dr. Shaalan Beg: GI25 featured major therapeutic advances across the spectrum of GI malignancies, and it was exciting to hear about innovations and novel approaches that are shaping the future of our field. Before we start talking about specific abstracts, could you share some of your key highlights from the meeting? Dr. David Wang: Sure. Our theme this year was “Breaking Boundaries to Enhance Patient Centered Care.” Past years' themes have focused more on precision oncology, but we wanted to broaden our focus on patients and to be more holistic, which kind of led us into some of the Intersection [sessions] that we had. Each day started with a different Intersection. The first one was “Emerging Therapies in GI Cancers”, where invited speakers talked about bispecific antibody drug conjugates, theranostics, CAR T and other cell-based therapies. The second day was on “Personalized Risk Assessment for GI Cancers,” and this included looking at polygenic risk scores for colorectal cancer, microRNAs and liquid biopsies such as exosomes and pancreatic cancer and non-endoscopic screening modalities in esophageal cancer. And on our final day, we wanted to talk about “Integrative Oncology and Integrative Medicine,” looking at evidence-based uses of acupuncture and supplements in patients who are receiving treatment for cancer, mindfulness-based practices and exercise. And of course, we had a fantastic keynote talk by Dr. Pamela Kunz from the Yale School of Medicine titled, “Disrupting Gastrointestinal Oncology: Shattering Barriers with Inclusive Science.” She highlighted the intersection of science, patient care, and health and gender equity. And I would encourage your podcast listeners to access the lecture in ASCO's Meeting Library if they haven't yet had a chance to hear Dr. Kunz's wonderful lecture.  We were really happy this year because the attendance hit a new record. We had over 5,000 people attend either in person or virtually from their home or office, and we had almost 1,000 abstracts submitted to the meeting, so these were either record or near record numbers. We offered a lot of different networking opportunities throughout the meeting, and attending found these to be incredibly rewarding and important and this will continue to be an area of emphasis in future meetings. Dr. Shaalan Beg: Let's take a deeper dive into the exciting studies presented at GI25. The late breaking abstract LBA143 was CheckMate-8HW. This was the first results of NIVO + IPI versus NIVO monotherapy for MSI-high metastatic colorectal cancer. What are your thoughts about this study? Dr. David Wang: Yeah, so we know that colorectal cancer patients with MSI-high tumors don't necessarily respond well to chemotherapy. And we were fortunate because last year CheckMate-8HW actually looked at two different arms – so this was NIVO + IPI compared to standard of care chemotherapy and showed its very significant improvement in median progression-free survival. And that was actually published in the New England Journal of Medicine back in November of 2024. This year's presentation actually focused now on NIVO + IPI versus NIVO monotherapy. And as you know IPI+NIVO can be quite toxic. So this was an important analysis to be done. So we know that NIVO is definitely more easily tolerated. So what was interesting was that the 2-year and 3-year progression-free survival not surprisingly favored IPI+NIVO and this was statistically significant. And the overall response rate was also better with IPI+NIVO versus NIVO alone. I know we're always concerned about toxicities and there were higher grade 3 and 4 toxicity incidences in the combination arm versus the monotherapy arm, but overall, only about 28 additional events in several hundred patients treated. So I think that's well-tolerated. Our discussant Dr. Wells Messersmith actually said that, with this new data, he would consider doing combination immunotherapy in any patient that presented in the front line with MSI-high or deficient mismatch repair colorectal cancer that was metastatic. Dr. Shaalan Beg: One of the focuses for directing first-line therapy for colorectal cancer has been right and left sided colon cancer because we know these are two different cancers with their own unique molecular subtypes. We heard on Abstract 17, the DEEPER trial, the final analysis of modified FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left sided metastatic colorectal cancer. How do you summarize the findings of this study and what should our readers be aware of? Dr. David Wang: Interestingly, this was a phase 2 study and the emphasis of the abstract was actually a subgroup analysis of those patients with RAS wild-type and BRAF wild-type as well as left sided cancers. So, I think the entire study enrolled 359 patients, but the analysis that was discussed at the meeting really focused on 178 patients that fit that characteristic. Very similar to what we've seen in prior studies, left-sided tumors have better response to cetuximab versus bevacizumab. And if you flip it so that you now are looking at right sided tumors, targeting EGFR is actually detrimental. The depth of response was better with cetuximab in these left sided RAS and BRAF mutant tumors. And so the lead author actually suggested that this could be a new first-line standard of care. And the question is, is there a benefit of doing this triple agent regimen with modified FOLFIRINOX? We know there's a lot more toxicity with that. Not clear that there's a benefit for that over FOLFOX, maybe in younger patients that could tolerate it. When our discussant, again Dr. Wells Messersmith, spoke about this, he said that, in his practice he would, again, favor cetuximab over bevacizumab in combination with chemo, these left-sided RAS and BRAF wild-type tumors, but that he would actually prefer a doublet versus a triplet chemo regimen, and that is consistent with the current NCCN guidelines. Dr. Shaalan Beg: Another area where colorectal cancer has been a wonderful model to study new technology has been in the area of circulating tumor DNA (ctDNA). And the BESPOKE CRC trial is looking to see if ctDNA can inform adjuvant treatment decisions for stage II and III colorectal cancer. And in Abstract 15, we heard final results of the BESPOKE CRC sub-cohort. What were the findings there? Dr. David Wang: BESPOKE CRC is another one of these important ctDNA studies. It was an observational study, not a randomized trial, but it did provide a lot of different insights to us. We know that there were over 1,700 patients enrolled, and so it was reported that this is the largest ctDNA study in colorectal cancer performed in the United States. And they were able to analyze over 1,100 patients.  Some of the key findings were that postoperative adjuvant therapy management decisions actually changed in 1 out of 6 patients, so that's pretty significant. In terms of surveillance, we know that patients who have ctDNA positivity, this is prognostic of recurrence. In terms of patients who have positive ctDNA post-surgery, it looked like, at least in this observational study, the majority of patients who received any benefit were those who had positive ctDNA. So adjuvant therapy, even in stage II and stage III patients seemed to only benefit those patients who have positive ctDNA. I think that does raise the question, and this also was brought up in the discussion, which is “Can we de-escalate adjuvant therapy in terms of patients who are ctDNA-negative post-op?” And Dr. Richard Kim from Moffitt felt that we are not yet there. Obviously, we need randomized control trials where we are taking ctDNA results and then randomizing patients to receive adjuvant or non-adjuvant to really know the difference.  Other questions that come up with use of ctDNA include: What do you do with these patients who turn positive? This study for BESPOKE actually followed patients out to two years after surgery. So what you do with a positive ctDNA result wasn't really clear. It seems to suggest that once you turn positive, patients go on to more intensive surveillance. You know, again as an observation, patients who did turn positive were able to go to metastasis-directed therapy much more quickly. And again, this was supposedly to improve their curative intent therapy. And I think the other question that has been brought up all the time is, is this really cost effective? Patients want to know, and we want to give patients that information, but I think we're still stuck with what to do with a positive ctDNA level in a patient that's on surveillance because no randomized control studies have actually suggested that we need to start systemic therapy right away. Dr. Shaalan Beg: Yeah. And I guess in terms of practice informing or practice changing, these results may not give us a clear answer. But because a lot of patients are asking for these tests, it does give us some real world experiences on what to expect in terms of conversion of these positive into negative and the outcome so we can have a shared decision making with our patients in the clinic and then come up with a determination on whether ctDNA for molecular residual disease is something which would be worthwhile for the care of our patient. But more to come, I guess, in coming years to answer different problems around this challenge. Dr. David Wang: Yes, I agree. Dr. Shaalan Beg: The BREAKWATER trial looked at the use of encorafenib, cetuximab and chemotherapy for BRAF V600E-mutant metastatic colorectal cancer. We've covered this combination for a second- third-line treatment in metastatic colorectal cancer previously. Abstract 16 from GI25 was evaluating the use of this regimen in the first-line space. Everyone was looking forward to these results, and what did the investigators present? Dr. David Wang: I think this is, as you mentioned, a nice follow up to later lines of therapy where Dr. Kopetz from MD Anderson pioneered use of encorafenib, cetuximab and binimetinib in the BEACON trial. Everybody was kind of curious what would happen now if you use encorafenib plus cetuximab plus chemotherapy in the first-line setting. And so this is an interim analysis that was pre-planned in the phase 3 open label BREAKWATER trial. And even though there were three arms, and so the three arms were encorafenib plus cetuximab, encorafenib plus cetuximab plus FOLFOX, or standard of care chemo, only two arms were presented in the abstract. So basically looking at encorafenib plus cetuximab and FOLFOX-6 versus standard of care therapy, and the overall response rate was statistically significant with a 60.9% overall response rate encorafenib plus cetuximab plus chemo arm versus standard of care chemo was only 40%. The interim overall survival also was different. It was 92% versus 87% at 6 months and 79% versus 66% at 12 months, again favoring the chemotherapy plus encorafenib plus cetuximab. In terms of the statistics, the p was 0.0004. However, the pre-plan analysis required the p-value to be 1x10 to the -8. And so even though this looks really good, it hasn't quite met its pre-specified significance level. The good thing is that this is only interim analysis and the study is ongoing with future analysis planned.  So the real question is: Does it matter when we actually use this regimen? We know that the regimen's approved in the second third-line setting. What about in the first line? And there was some preclinical data that the discussant reviewed that shows that patients actually benefit if this is done in the first-line setting. For example, there was some preclinical data showing that even FOLFIRI, for example, can upregulate RAS, which would make tumors more resistant to this combination. This was thought to be practice-changing in a patient that has B600E showing up treatment naive that we should probably consider this regimen. And actually this did receive accelerated FDA approval about a month ago. Dr. Shaalan Beg: Yeah, and for what it's worth, I put up a Twitter poll asking my Twitter followers on how the BREAKWATER trial results will change their approach for newly diagnosed BRAF mutated colorectal cancer. We got 112 responses; 72% said that they will incorporate encorafenib, cetuximab, FOLFOX for their frontline BRAF mutated patients. But 23% said that they would like to wait for overall survival results. Dr. David Wang: Wow, that's interesting. They really want that 1x10 to the -8. Dr. Shaalan Beg: I guess so. All right. Let's change gears and talk about esophageal cancer. LBA329 was the SCIENCE study which presented preliminary results from a randomized phase 3 trial comparing sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant resectable locally advanced squamous esophageal cancer. Where are we in this space? Dr. David Wang: Okay. So, yeah, this was an interesting trial. Again, just to set the context, esophageal squamous cell carcinoma is more prevalent in Asia. And the study sites as well as the patients were mostly from Asia. So this was again a phase 3 trial with interim results. They only rolled 146 out of the planned 420 for this interim analysis. And yeah, they're using immune checkpoint inhibitor that we don't use in the United States, sintilimab, combined with their two standards of neoadjuvant therapy, either chemotherapy, which is more common in Asia, or or chemoradiation, which is more common in the US and Western Europe, versus chemoradiation. And so they actually had two primary endpoints, but only were reporting one. So their two primary endpoints were pathCR and the other one was event-free survival. The event-free survival, again, was not reported at the meeting.  What they found was that in terms of pathCR rate, if you take the two arms that are really informative about that, chemoradiation plus sintilimab versus chemoradiation alone, the pathCR rate was 60% versus 47%. We know that chemo alone doesn't induce as much of a pathCR rate, and that was 13%. So it was found that the delta in terms of pathCR between the chemoradiation arms, one with sintilimab and one without, was significant. And this actually confirms data again from Asia, like for the ESCORT-NEO trial where it used another immune checkpoint inhibitor pembrolizumab in addition to neoadjuvant chemo.  So as our discussant for this abstract said, yes, we know that radiation combined with chemotherapy improves pathCR rates, but we have recent data from the ESOPEC trial, we don't know that that necessarily will translate to overall survival. So again, waiting for additional enrollments and longer term follow up before incorporating this into clinical care here. Dr. Shaalan Beg: So David, how do the results of the SCIENCE trial compare with our practice in the United States and ongoing studies asking questions for neoadjuvant therapy for esophageal carcinoma in the United States? Dr. David Wang: I think obviously immune checkpoint inhibitor in the new adjuvant setting is important. Jennifer Eads at UPenn is running that EA2174 which is looking at chemoradiation plus or minus nivolumab, and then in non-pathCR responders randomized to adjuvant nivolumab per CheckMate 577 or nivolumab with intensification adding ipilimumab. We know that the ESOPEC trial just came out, and was published actually during the meeting, and that really focuses on adenocarcinomas. So adenocarcinomas of the GE junction, distal esophagus, now, we would probably treat very similarly to gastric using perioperative FLOT. However, the standard in the US for esophageal squamous cell carcinoma remains neoadjuvant chemoradiation. We know that squamous cell carcinomas are more exquisitely sensitive to radiotherapy. And then obviously in those patients who don't achieve a pathologic complete response, the expectation would be that they would go on to receive nivolumab per CheckMate 577. Again, the thought is that these tumors are more sensitive to immunotherapy given their higher incidences of mutational changes. And so again, this kind of goes along with the positive results seen in the SCIENCE trial that we just discussed with sintilimab but also EFFECT-neo with pembrolizumab. Obviously, we await the results of Jennifer's trial. Dr. Shaalan Beg: And the last abstract I was hoping we could get your perspective on was Abstract 652, which is a Phase 3 study of everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumors, the STARTER-NET trial. What were the results of this study? Dr. David Wang: So, I just want to give a shout out because we did have a session at this year's GI ASCO that looked at more rare tumors. So appendiceal tumors, neuroendocrine tumors, those kinds of things. So again, I would encourage your listeners to listen to that session if they have interest in that. Another type of rare tumor was adenosquamous tumors.  But in terms of the STARTER-NET trial, this was again an interim analysis of his phase 3trial and it was looking at combining everolimus plus lanreotide versus everolimus. So we know that in pancreatic-gastric neuroendocrine tumors, if you have low Ki-67, a well differentiated tumor, that the standard of care really is a somatostatin analog, and sometimes if they're more aggressive, we kind of consider molecular targeted therapy with everolimus. This was asking the question of whether we should do the combination on the frontline. And what was interesting is in this study, the patients were actually more of a poor prognostic set. So they had Ki-67 up to 20% or these were patients that actually had multiple liver lesions. And what they found was a median for progression free survival was improved with a combination out to 29.7 months versus 11.5 months with the somatostatin analog alone, and that the overall response rate was 23% versus 8.3%, again, favoring the combination. If you looked at subgroup analysis, it was actually those patients who had Ki-67 greater than 10%, so the more aggressive tumors, or those with diffuse liver lesions that had the most benefit. So I think that would be the patient population I would consider this new combination with using would be those patients again with poorer prognosis neuroendocrine tumor phenotype. Dr. Shaalan Beg: Thank you very much, Dr. Wang, for sharing your insights with us today and your great work to build a robust GI Cancers Symposium this year. Dr. David Wang: Well, thank you. I mean that really is a cooperative effort. We appreciate all the members of the GI25 Program Committee as well as the ASCO staff that just made it an outstanding meeting. Dr. Shaalan Beg: And thank you to all our listeners for your time today. You'll find links to the abstracts discussed today on the transcript of this episode.  Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:  Dr. Shaalan Beg @ShaalanBeg  Dr. David Wang Follow ASCO on social media:   @ASCO on Twitter  @ASCO on BlueSky ASCO on Facebook   ASCO on LinkedIn   Disclosures:  Dr. Shaalan Beg:  Employment: Science 37  Consulting or Advisory Role: Ipsen, Array BioPharma, AstraZeneca/MedImmune, Cancer Commons, Legend Biotech, Foundation Medicine  Research Funding (Inst.): Bristol-Myers Squibb, AstraZeneca/MedImmune, Merck Serono, Five Prime Therapeutics, MedImmune, Genentech, Immunesensor, Tolero Pharmaceuticals  Dr. David Wang: Honoraria:  Novartis Consulting or Advisory Role: Novartis, Cardinal Health, Bristol-Myers Squibb, BeiGene, Eisai  

In this episode of The Real Health Podcast, Dr. Ron Hunninghake, MD welcomes Dr. Dan Rubin, ND, FABNO, a pioneer in naturopathic oncology and co-founder of the American Board of Naturopathic Oncology. Together, they dive into the importance of integrative oncology, the role of dendritic cell therapy, and how blending conventional and naturopathic approaches can empower cancer patients. Dr. Rubin shares insights into the "resilience model" of cancer care, immune system optimization, and the critical role of personalized medicine in improving outcomes and quality of life.Learn more about the hosts:Dr. Dan Rubin, ND FABNO: https://listenandcare.com/dan-rubin-nd-fabno/Dr. Ron Hunninghake, MD: https://riordanclinic.org/staff/ron-hunninghake-md/Read the transcript:https://realhealthpodcast.org/2025/01/revolutionizing-cancer-care/Learn more about Riordan Clinic:https://riordanclinic.org/Interested in becoming a Patient:https://riordanclinic.org/request-an-appointment/Thanks to This Episode's SponsorRiordan Clinic Nutrient Store: https://store.riordanclinic.org/Disclaimer: The information contained on the Real Health Podcast and the resources mentioned are for educational purposes only. They're not intended as and shall not be understood or construed as medical or health advice. The information contained on this podcast is not a substitute for medical or health advice from a professional who is aware of the facts and circumstances of your individual situation. Information provided by hosts and guests on the Real Health Podcast or the use of any products or services mentioned does not create a practitioner-patient relationship between you and any persons affiliated with this podcast.

Dr. Michael Karlfeldt offers a deep dive into integrative oncology and the importance of immune support, especially during the winter season. he delves deep into the immune-protective benefits of fermented wheat germ extract and AHCC, which combine in ImmPower PLUS to offer comprehensive immune enhancement, cancer prevention, and treatment support. The discussion highlights the role of natural killer cell activity, the Warburg effect, and the adaptogenic properties of these supplements in addressing both cancer and general immune health. Practical dosing recommendations and Dr. Karlfeldt's insights into the integration of conventional and alternative therapies provide valuable knowledge on how to bolster immune systems effectively.

Dr. Hoffman continues his conversation with Dr. Michael Karlfeldt, ND, Ph.D., an expert in Integrative Oncology, about the immune-protective effects of ImmPower PLUS AHCC + FWGE-SC. Use coupon code HOFFMAN10 at checkout to get a 10% discount and free shipping.

EVEN MORE about this episode!Join us for an inspiring conversation with Karla Mans Giroux, co-director of the Radical Remission Project, as she reveals the powerful secrets behind radical remission. Discover life-changing stories of individuals who conquered cancer by combining conventional medicine with emotional, lifestyle, and spiritual healing.Learn about Dr. Kelly Turner's groundbreaking research on the ten factors common among over 1,500 survivors, including the role of self-advocacy, emotional well-being, and the mind-body connection. This episode is filled with hope and practical insights that empower cancer patients—and anyone facing chronic illness—to take control of their healing journey.With tips on diet, exercise, and intuition, Karla shows how healing is a deeply personal, holistic experience. Plus, hear from a survivor who healed through a unique blend of medical and holistic practices. Don't miss this chance to explore the life-altering power of radical remission!Guest Biography:Karla Mans Giroux is the Co-Director of the Radical Remission Project, Co-Founder of Health Navigators, and a holistic cancer health coach, educator, and speaker. A metastatic breast cancer (MBC) survivor thriving with No Evidence of Disease since 2016, Karla was originally diagnosed in 2003 and faced a recurrence in 2014.Determined to live beyond the odds, Karla embraced a holistic healing journey, achieving remission and inspiring others to do the same. Certified by the Wisdom of the Whole Coaching Academy, the Radical Remission Project, and NBHWC, she co-founded Health Navigators in 2020, creating a Virtual Cancer Wellness Community.As a Radical Remission workshop instructor, podcast co-host, and health coach, Karla shares the transformative power of Radical Remission healing factors, empowering others to take charge of their health and well-being.Episode Chapters:(0:00:01) - What Is Radical Remission?(0:08:48) - Integrative Oncology and Cancer Survivorship(0:24:53) - Navigating Resistance in Cancer Care(0:32:01) - The Power of Mind-Body Healing(0:40:19) - Diet, Intuition, and Emotional Healing(0:55:38) - Improving Quality of Life Through Workshops(1:05:33) - The Purpose of Incarnation and Cancer(1:11:40) - Empowering Conversations on Fighting CancerPlease join Julie next week with your question.Thursdays at 8pm ET, 7pm CT, 5pm PT.https://askjulieryanshow.comAnd, please leave a five-star review and subscribe so you can hear all the new episodes.Sponsors & RecommendationsDisclaimer: This show is for informational purposes only. It is not intended to be medical, psychological, financial or legal advice. Please contact a licensed professional. The Ask Julie Ryan show, Julie Ryan, and all parties involved in producing, recording and distributing it assume no responsibility for listener's actions based on any information heard on this or any Ask Julie Ryan shows or podcasts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today, Dr. Robert Whitfield is joined by Dr. Nasha Winters, a naturopathic physician who emphasizes the importance of personalized care in cancer treatment. Dr. Winters discusses the “hallmarks of cancer” and the need for a holistic approach to treatment that considers diet, environment, and lifestyle. Despite advancements in understanding cancer biology, overall survival rates haven't improved significantly, which points to the necessity of more nuanced care. Her insights bring a fresh perspective on integrative oncology, which is crucial for patient outcomes. Be sure to tune in to hear more! Show Highlights: Challenges in Rural Healthcare (00:04:02) Dr. Whitfield highlights the difficulties of accessing advanced medical care in rural areas. Implant-Related Complications (00:03:36) Dr. Winters shares experiences of patients facing complications from medical implants and the need for support. Chronic Inflammatory Processes (00:17:16) Breast implants as part of a chronic inflammatory process affecting patients Enlightenment from a Cancer Patient (20:11) Dr. Whitfield shares how a cancer patient in 2016 taught him about the complexities of breast implant issues. Addressing Genetic Mutations (30:51) The role of genetics in cancer and the importance of environmental factors in health Hallmarks of Cancer (00:40:05) Overview of the evolving concept of cancer hallmarks and their implications for treatment strategies The Importance of Individualized Care (00:43:31) Emphasizing the uniqueness of each patient and the need for tailored treatment strategies Integrative Oncology Resources (00:56:09) Resources for learning about holistic oncology care and ongoing research efforts Connect with Dr. Whitfield Podcast (https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554) Spotify (https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667) TikTok (https://www.tiktok.com/@drrobertwhitfield?_t=8oQyjO25X5i&_r=1) IG (https://www.instagram.com/breastimplantillnessexpert/) FB (https://www.facebook.com/DrRobertWhitfield) Linkedin (https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/) X.com (https://x.com/rjwhitfield?lang=en) Read this article (https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness) Shop Dr. Whitfield's Solutions (https://drrobssolutions.com) SHARP (https://www.harp.health) NVISN Labs (https://nvisnlabs.com/) Get access to Dr. Rob's Favorite Products below: Danger Coffee (https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg) - Use our link for mold-free coffee. JASPR Air Purifier (https://jaspr.co/)- Use code DRROB for the Jaspr Air Purifier. Echo Water (https://echowater.com/)- Get high-quality water with our code DRROB10. BallancerPro (https://ballancerpro.com) - Use code DRROBVIP for the world's leader in lymphatic drainage technology. Ultrahuman (https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield)- Use code WHITFIELD10 for the most accurate wearable. Connect with Dr. Nasha Winters Dr. Nasha's Website (https://www.drnasha.com/) Dr. Nasha's podcast - Metabolic Matters (https://podcasts.apple.com/us/podcast/metabolic-matters/id1702761393) Books Mentioned Ravenous (https://amzn.to/41sG92H)by Sam Appel The Metabolic Approach to Cancer, (https://amzn.to/4g649gQ) by Dr. Nasha Winters and Jess Higgins Kelley Mistletoe and the Future of Integrative Oncology, (https://amzn.to/3ZOzu1y) by Steven Johnson, DO, Dr. Nasha Winters

When it comes to cancer care—from the specific diet you follow to the type of treatment you subject your body to—quality intervention is key. This week, I'm joined by Dr. Nasha Winters, an integrative oncologist and cancer "thriver" (she was diagnosed with stage 4 ovarian cancer at age 19), who is pioneering the future of cancer care. We sat down to discuss the root cause of the illness, the importance of doing a self-audit of your home and habits, and why there is a time and a place for conventional cancer care. In this episode, you'll discover: Cancer Goes Beyond Genetics: Cancer was originally believed to be genetic, but recent research demonstrates that it's a metabolic disease. A common denominator among cancer cells is that they all have very damaged mitochondria (known as the powerhouse of the cell), shares Dr. Winters. "We were just looking at the wrong organelle all these years when the real organelle of interest was the mitochondria and the environment in which the mitochondria is swimming in and being exposed to," she adds. Why a Self-Audit Is a Non-Negotiable: An easy first step to change your terrain is knowing what you're putting on, in, and around your body. This can be anything from skincare products and kitchen utensils to water filtration systems and air fresheners. "The more we're exposed to at a younger age, the more our nervous systems, our immune systems, and our metabolic systems are wired differently to make us more vulnerable to disease in general and cancer in particular," says Dr. Winters. Making small lifestyle changes can lead to a big, sustainable impact. Blending Two Types of Care Is Vital: Despite her lifelong mission to educate patients and practitioners on the transformative benefits of integrative medicine, Dr. Winters isn't here to villainize conventional cancer treatments. She does, however, stress the importance of marrying the two—based on your individual needs and diagnosis. It's important to ask yourself, says Dr. Winters: "How can I make the standard of care effective with as few toxins as possible while simultaneously protecting the healthy cells and strengthening the environment, the terrain in which cancer happens?" 00:49 Dr. Nasha's Cancer Journey 08:23 Accidental Discoveries and Fasting Benefits 16:02 Nutritional Changes and Health Improvements 22:35 Exploring Metabolic and Mitochondrial Theories of Cancer 27:42 Debunking the Genetic Mutation Theory of Cancer 28:33 The Role of Mitochondria in Cancer 29:30 Changing the Environment to Combat Cancer 30:13 Self-Audit: Evaluating Your Surroundings 33:43 The Impact of Conventional Treatments on Cancer 35:43 A New Approach to Cancer Treatment 44:54 The Vision for a New Cancer Hospital Connect with Dr. Myers: Website: https://www.amymyersmd.com/ Newsletter: https://www.amymyersmd.com/ec/guide-to-leaky-gut Facebook: https://www.facebook.com/AmyMyersMD Instagram: https://www.instagram.com/amymyersmd/ Connect with Dr. Winters: Website: https://www.drnasha.com/ Podcast - Metabolic Matters: https://www.drnasha.com/metabolic-matters Metabolic Terrain Institute of Health (non-profit & training): https://www.mtih.org/ Books: https://www.drnasha.com/books-and-education Mitovida: https://mitovida.com/

In recent years, many doctors and researchers have shared critical health information and have been censored and discredited for doing so, despite their long esteemed history and contributions to the field. Nobody has faced more obstacles to sharing the truth than Dr. Paul Marik. On this episode of Vitality Radio, Jared has the honor of inviting this hero of ours on to the show to share about the role of repurposed drugs and metabolic interventions in treating cancer. These approaches pick up where traditional cancer therapies leave off, with creative interventions, backed by science, showing that they can improve patient outcomes. This is the show you'll want to listen to now, save for later, and share with anyone you know facing cancer.Additional Information:Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer by Dr. Paul Marik - bookVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this episode, we are joined by Dr. Melvin Nario, MD, HMD, an integrative and homeopathic medical doctor with a diverse background that spans conventional and alternative medicine. With his training in both traditional Western medicine and homeopathy, Dr. Nario takes a holistic approach to healthcare, focusing on personalized treatments that address the root causes of illness. He is particularly known for his expertise in peptide therapies, anti-aging medicine, and integrative oncology, combining cutting-edge science with natural healing methods.  Episode Highlights: Dr. Nario's Medical Journey**: Learn about Dr. Nario's unique path, from his medical degree at the University of Santo Tomas in the Philippines to becoming a licensed homeopathic doctor in Nevada, integrating both worlds of medicine. Peptide Therapy**: Discover the exciting potential of peptide therapies in enhancing healing, boosting immune function, and supporting anti-aging. Dr. Nario shares how these therapies can regulate hormones, improve cognitive function, and promote tissue repair. Integrative Oncology**: Dr. Nario discusses his work at Forsythe Cancer Center and Bio Integrative Health Center, where he uses a holistic approach in treating cancer, combining integrative methods such as IV nutrient therapies and botanicals with conventional treatments. IV Nutrient Therapies**: Learn about the powerful effects of IV therapies, including NAD+ for cellular repair and anti-aging, chelation for detoxification, and nutritional IVs for overall health optimization. Homeopathy & Classical Medicine**: How Dr. Nario blends homeopathy with acute and chronic care, giving patients personalized, non-toxic options for healing and long-term wellness. Anti-Aging and Regenerative Medicine**: Dr. Nario shares insights from his work in the field of anti-aging, discussing how modern advancements like peptide therapies and IV nutrients are transforming the landscape of longevity medicine. Key Takeaways: - The science behind **peptide therapies** and their role in anti-aging, cognitive enhancement, and immune support. - How Dr. Nario combines **traditional Western medicine** with **holistic approaches** to provide a comprehensive care plan for his patients. - The potential of **integrative oncology** to enhance conventional cancer treatments with natural and supportive therapies. - Why **IV nutrient therapies** are growing in popularity for both disease treatment and preventive health. es. Connect with Dr. Melvin Nario: - Bio Integrative Health Center: https://www.facebook.com/biointegrativereno/ - Forsythe Cancer Center:  https://www.drforsythe.com/ - Clearfield Medical Group: https://drclearfield.net/?utm_source=google&utm_medium=organic&utm_campaign=gmb Be sure to subscribe to our channel for more insightful conversations with experts in integrative and longevity medicine!   BIO Nario, Melvin Ibarra MD HMD Current Address: 6292 Dog Hollow Court Reno NV 89519, melvin_nario@yahoo.com Main Credentials: 1.)    M. D. Degree Doctor of Medicine – University of Santo Tomas, Manila, Philippines 2.)    Licensed Homeopathic Medical Doctor (MD HMD) – State of Nevada 3.)    Internship - Residency Program in University of North Dakota, Bismarck Family Medicine 4.)    Internship in University Of Santo Tomas Hospital, Philippines 5.)    Doctor Of Medicine and B.S. Degree in Nursing, University of Santo Tomas, Manila 6.)    Degree in Acute and Chronic Classical Homeopathy, British Institute of Homeopathy 7.)    Former Medical Director – The Vitality Bar in Fitness For 10 Sparks, Nevada 8.)    Former Medical Director of Bio Integrative Health Center International Reno, Nevada 9.)    Visiting Physician – Forsythe Cancer Center and Clearfield Medical - Reno, Nevada 10.)    Junior faculty physician – American Academy of Anti-Aging Medicine (A4M) Women's Hormone Course 11.)    Vice President of the Nevada Homeopathic Board Of Examiners 12.)    Licensed Advanced Nurse Practitioner and RN, Nevada 13.)    Licensed RN – Philippines Certifications: 1.)    ECFMG Certified 2.)    Certified in the Fundamentals/Advanced Clinical Applications of IV Nutrient Therapies 3.)    Certified Shoemaker Proficiency Partner practitioner for CIRS 4.)    Academy of American Anti Aging Medicine Certifications – Peptide Therapy, integrative oncology, CIRS (Chronic Inflammatory Response Syndrome) 5.)    IV Therapeutics Certified – NAD, Integrative Oncology, Botanicals, Antiaging, Chelation, Nutritional 6.)    Institute for Functional Medicine  -  Member  Work Experience  8/8/2023 – present: Visiting Physician Clearfield Medical, Reno, Nevada 6/2015 – present: Bio Integrative Health Center International Reno – Health Care Provider (MD HMD) 6/2018 – present: Visiting Physician – Forsythe Cancer Center - Forsythe Cancer Care Center Reno, Nevada   Personalised Health Optimisation Consulting with Lisa Tamati Lisa offers solution focused coaching sessions to help you find the right answers to your challenges. Topics Lisa can help with:  Lisa is a Genetics Practitioner, Health Optimisation Coach, High Performance and Mindset Coach. She is a qualified Ph360 Epigenetics coach and a clinician with The DNA Company and has done years of research into brain rehabilitation, neurodegenerative diseases and biohacking. She has extensive knowledge on such therapies as hyperbaric oxygen,  intravenous vitamin C, sports performance, functional genomics, Thyroid, Hormones, Cancer and much more. She can assist with all functional medicine testing. Testing Options Comprehensive Thyroid testing DUTCH Hormone testing Adrenal Testing Organic Acid Testing Microbiome Testing Cell Blueprint Testing Epigenetics Testing DNA testing Basic Blood Test analysis Heavy Metals  Nutristat Omega 3 to 6 status and more  Lisa and her functional medicine colleagues in the practice can help you navigate the confusing world of health and medicine . She can also advise on the latest research and where to get help if mainstream medicine hasn't got the answers you are searching for whatever the  challenge you are facing from cancer to gut issues, from depression and anxiety, weight loss issues, from head injuries to burn out to hormone optimisation to the latest in longevity science. Book your consultation with Lisa    Join our Patron program and support the show Pushing the Limits' has been free to air for over 8 years. Providing leading edge information to anyone who needs it. But we need help on our mission.  Please join our patron community and get exclusive member benefits (more to roll out later this year) and support this educational platform for the price of a coffee or two You can join by going to  Lisa's Patron Community Or if you just want to support Lisa with a "coffee" go to  https://www.buymeacoffee.com/LisaT to donate $3   Lisa's Anti-Aging and Longevity Supplements  Lisa has spent years curating a very specialized range of exclusive longevity, health optimizing supplements from leading scientists, researchers and companies all around the world.  This is an unprecedented collection. The stuff Lisa wanted for her family but couldn't get in NZ that's what it's in her range. Lisa is constantly researching and interviewing the top scientists and researchers in the world to get you the best cutting edge supplements to optimize your life.   Subscribe to our popular Youtube channel  with over 600 videos, millions of views, a number of full length documentaries, and much more. You don't want to miss out on all the great content on our Lisa's youtube channel. Youtube   Order Lisa's Books Lisa has published 5 books: Running Hot, Running to Extremes, Relentless, What your oncologist isn't telling you and her latest "Thriving on the Edge"  Check them all out at  https://shop.lisatamati.com/collections/books   Perfect Amino Supplement by Dr David Minkoff Introducing PerfectAmino PerfectAmino is an amino acid supplement that is 99% utilized by the body to make protein. PerfectAmino is 3-6x the protein of other sources with almost no calories. 100% vegan and non-GMO. The coated PerfectAmino tablets are a slightly different shape and have a natural, non-GMO, certified organic vegan coating on them so they will glide down your throat easily. Fully absorbed within 20-30 minutes! No other form of protein comes close to PerfectAminos Listen to the episode with Dr Minkoff here:    Use code "tamati" at checkout to get a 10% discount on any of their devices.   Red Light Therapy: Lisa is a huge fan of Red Light Therapy and runs a Hyperbaric and Red Light Therapy clinic. If you are wanting to get the best products try Flexbeam: A wearable Red Light Device https://recharge.health/product/flexbeam-aff/?ref=A9svb6YLz79r38   Or Try Vielights' advanced Photobiomodulation Devices Vielight brain photobiomodulation devices combine electrical engineering and neuroscience. To find out more about photobiomodulation, current studies underway and already completed and for the devices mentioned in this video go to www.vielight.com and use code “tamati” to get 10% off     Enjoyed This Podcast? If you did, subscribe and share it with your friends! If you enjoyed tuning in, then leave us a review and share this with your family and friends. Have any questions? You can contact my team through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts.  To pushing the limits, Lisa and team  

Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21) Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu previews the upcoming IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC. To discuss this exciting new meeting and this topic, he is joined by the four co-chairs of the meeting. To learn more about the meeting, visit https://www.httr2024-iaslc.org/. Guest: Dr. Alice Berger is an Associate Professor in the Human Biology Division and the Herbold Computational Biology Program at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, Wash. X: @aliceb_phd Guest: Dr. Kenichi Suda, Associate Professor in the Division of Thoracic Surgery at Kindai University School of Medicine in Osaka, Japan. X: NA Guest: Dr. Montse Sanchez-Cespedes is the Group Leader at the Josep Carreras Research Institute, in Badalona, Spain X: @CespedesMontse Guest: Dr. William Lockwood, Senior Scientist in Integrative Oncology at the BC Cancer Research Institute and Associate Professor in Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, Canada X: @WWL_18

In this episode of Integrative Cancer Solutions, we are joined by Professor Dr. Sarper Diler, a distinguished medical doctor and oncologist, to discuss his unique approach to cancer treatment through integrative oncology. Prof. Diler shares his personal cancer journey, highlighting his battle with a large kidney tumor, treated through a combination of traditional surgery and alternative methods, including radical nephrectomy and the Gonzalez protocol.Key Discussion Points:Personalized Cancer Treatment: Prof. Diler emphasizes the importance of tailoring treatments to the individual, including the integration of pancreatic enzymes, specific diets, and detoxification. He shares insights into the Gonzalez protocol, which combines these elements to help support the body's natural healing processes.The Role of Pancreatic Enzymes: Drawing on historical and modern applications, Prof. Diler explains how pancreatic enzymes are used in cancer treatment and their significance in improving patient outcomes.Prof. Diler's Cancer Journey: From the moment he was diagnosed with a kidney tumor, Prof. Diler's experience shaped his transition from conventional oncology to integrative methods. His personal treatment approach, involving both surgery and alternative therapies, demonstrates the power of holistic cancer care.Belief and Compliance: One of the key takeaways from Prof. Diler's experience is the critical role of patient belief and adherence to the treatment protocol. He stresses that success with the Gonzalez protocol requires full commitment and belief in the process.Advancements in Cancer Treatment: Prof. Diler also touches on emerging technologies in cancer care, such as the potential for using wearable devices to deliver pancreatic enzymes, a field being researched at the Orbital Institute.Success Stories: Prof. Diler shares powerful testimonials of patients who have followed the Gonzalez protocol and experienced improved energy, mood, and quality of life.Action Items:Explore the Gonzalez Protocol website to learn more about integrative cancer treatments.Explore the Ovital Institute to learn moreConclusion:Dr. Diller's insights into integrative oncology offer hope and valuable knowledge for cancer patients and their families. Tune in to learn more about how personalized treatments can improve both quality of life and health outcomes.Be sure to visit the Karlfeldt Center website for more resources and information on future consultations.About Prof. Sarper Diler:He is the director of OVITAL Institute and serves as the Chair of the Scientific Advisory Board for the Nicholas Gonzalez Foundation in the US. He is highly active in numerous international scientific and patient-focused groups and committees.His previous roles include serving as the President of Myeloma Patients Europe (MPE), as a member of the European Cancer Organization Patient Advisory Committee (ECCO-PAC), the European Cancer Concord (ECC), and as Secretary General and Board Member of the Lymphoma Association (LC).Prof. Diler is a certified International Stem Cell Transplant Coordinator (CHTC) at the American National Donor Program (NMDP) and a specialist in Cancer Diet, Microbiome, and Heart Rate Variability, with certifications from Colorado Boulder and Arizona Universities, respectively. As an Integrative Oncologist, he holds memberships with SIO and BSIO. Additionally, he is a certified homeopath through the European Committee for Homeopathy (ECH) and the London College of Homeopathy (LCH).He has authored over 200 scientific articles and currently offers unique services worldwide under the umbrella of OVITAL Institute and OVITAL International Consultancy. His work also includes running preclinical and clinical trials focused on Cancer, Autonomic Nervous System clinical interferences, Epigenetics, Gut-Heart-Brain axis coherence, and Quantum diagnostics and treatments.----Grab my book A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health Threat - https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 ----Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

In this episode (part 1 of a 2-part series), we explore the misunderstood world of cancer with renowned integrative oncology expert, Dr. Thomas Lodi. The medical industry often frames cancer as a death sentence, instilling fear that exceeds the true power this diagnosis should hold. Dr. Lodi offers a groundbreaking and empowering perspective, challenging the conventional view and redefining how we understand and approach cancer. For over 35 years, Dr. Lodi has transformed the cancer treatment landscape. After founding An Oasis of Healing in Arizona in 2005, he pioneered what has now become the definitive route for those unsatisfied with modern cancer treatments. Dr. Lodi's healing approach has revolutionized the integrative oncology industry worldwide. Through his innovative Stop Making Cancer course and weekly livestreams on social media, Dr. Lodi empowers individuals to take control of their health and focus on disease prevention and recovery. Join us as Dr. Lodi shares his powerful vision for a future where health restoration takes precedence over fear. ✴️ Connect with Dr. Lodi on Instagram, TikTok, or YouTube

In this powerful episode of the Balancing Chaos podcast, Kelley Nemiro sits down with Dr. Katie Deming, oncologist and healthcare leader who has dedicated her career to making the cancer experience just a little bit easier. After caring for thousands of patients and achieving major milestones in her career in traditional Western Medicine, Katie's life took a dramatic turn following a near-death experience in 2020. At the height of her professional success, having been nominated for the prestigious position of National Medical Director of Cancer Services for a healthcare system serving over 12 million Americans, Katie realized she needed to leave traditional oncology behind. This pivotal experience led her on a new path to explore deeper healing methods for cancer patients. While she continues to recognize the value of traditional cancer treatments like radiation, chemotherapy, and surgery, Katie now focuses on the mind-body connection and the conditions that support true wellness and healing. She is passionate about helping cancer patients navigate the bridge between conventional cancer care and integrative healing approaches.In this episode, Kelley and Katie dive deep into:The limitations of chemotherapy and radiation—how these treatments kill cells but don't cure cancer—and the critical role of bolstering the immune system to truly heal.The debate on whether cancer is driven more by genetics or lifestyle, and the surprising insights that Katie has discovered through her research.The importance of holistic well-being, including emotional, mental, and spiritual health, in both cancer prevention and recovery.Effective strategies to mitigate the stress of modern living and how reducing stress can prevent the development of cancer.How emotional management, supportive environments, and empowering communication are essential components of cancer treatment.Rethinking healthcare to emphasize patient independence and self-reliance on their healing journey.Katie's insights into the right diet and supplements for cancer prevention and supporting the healing process.This conversation is full of eye-opening revelations for anyone seeking a deeper understanding of how to approach cancer treatment holistically. Whether you're navigating cancer yourself, supporting a loved one, or interested in proactive health strategies, Katie's expertise and perspective will inspire and empower you.Tune in to learn how we can go beyond traditional treatments and embrace a more comprehensive approach to cancer care that addresses the root causes of illness and fosters true wellness.Links & Resources:Learn more about Katie Deming's integrative oncology services HEREFollow Kelley on Instagram HEREBook a lab review with Kelley HEREDon't forget to subscribe, rate, and review the Balancing Chaos podcast!

Dr. Chilkov is a Doctor of Oriental Medicine and leading authority and pioneer in the field of Integrative Cancer Care, cancer prevention, and immune enhancement. She is the Founder of the American Institute of Integrative Oncology and the creator of the OutSmartCancer® System and the author of the best-selling book : 32 Ways to OutSmart Cancer: How to Create a Body in Which Cancer Cannot Thrive. Her programs are recognized as the most comprehensive, science-based, safe, and natural programs for supporting cancer patients, cancer survivors, and health seekers looking to prevent cancer to Get Well, Stay Well, and Live Well beyond cancer. To learn more about Dr. Chilkov's pracitice visit - https://outsmartcancer.com To Download Your Speical Bonus Offer, "Recommended Supplements + OutSmart Cancer Healthy Living Shopping List", visit: http://outsmartcancer.com/radicalpodcast FB: https://www.facebook.com/DrNalini IG: https://www.instagram.com/drnalinichilkov/ YT - https://www.youtube.com/@DrNaliniChilkovLAcOMD ______ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram  YouTube ______ Thank you to our friends from Liber8 for sponsoring this episode of the podcast.  Are you struggling with the emotional toll of cancer? Discover Liber8's Precision Emotional Healing for Cancer, a 3-month online group program developed in collaboration with Dr Nasha Winters and designed to help you address the deep-rooted emotional traumas that can hinder your healing. Through a personalized approach and a supportive patient community, you'll transform fear into empowerment, vulnerability into strength, and grief into gratitude. Don't let emotional stress hold you back from healing. Join Precision Emotional Healing for Cancer and unlock your body's full potential for recovery. Visit www.liber8.health/radicalremission to start your transformation. Use code REMISSION10 for 10% off. Link: www.liber8.health/radicalremission  Social Media: Facebook - https://www.facebook.com/liber8.health Instagram - https://www.instagram.com/liber8.health/

integrative oncology at AHN full 283 Wed, 11 Sep 2024 14:45:49 +0000 2bQFIyn542HeHbCTxdJaKlkARzNR7v3W news,a-newscasts,top picks The Big K Morning Show news,a-newscasts,top picks integrative oncology at AHN The Big K Morning Show 2024 © 2021 Audacy, Inc. News News News News news News News News News

Have you ever wondered if there's more to cancer treatment than just chemotherapy and radiation? In this Longevity Podcast episode, I talk with Dr. Nasha Winters to discuss the often-overlooked mental and emotional aspects of healing from cancer. Dr. Winters, a stage 4 ovarian cancer survivor of over 30 years, shares her incredible journey and the unconventional approach that transformed her health and career.  We discuss the concept of "10 drops in the bucket" - factors that contribute to cancer development and overall health, including genetics, metabolism, toxins, microbiome, immune system, inflammation, circulation, hormones, circadian rhythm, and stress. We also dive into an integrative approach, combining the best of conventional and alternative treatments, tailored to each individual's needs, the concept of metronomic chemotherapy - using lower doses more frequently, potentially reducing side effects while maintaining efficacy, psychedelic therapy (mushrooms), and much more.     Dr. Nasha Winters is an integrative oncology specialist, author of "The Metabolic Approach to Cancer” and “Mistletoe and the Emerging Future of Integrative Oncology,” host of the Metabolic Matters podcast, and Executive Director of the nonprofit organization, the Metabolic Terrain Institute of Health (MTIH).   Thank you to our sponsors for making this episode possible: Vitali: Visit https://www.vitaliskincare.com/discount/Nathalie20 and use code Nathalie20 to save on your order. ARMRA: Go to tryarmra.com/NAT or enter NAT to get 15% off your first order. LVLUP: Use code NAT10 to save 10% off at https://lvluphealth.com/   Find more from Dr. Nasha Winters:  Website:  https://www.drnasha.com/  Podcast: Metabolic Matters Books: The Metabolic Approach to Cancer   Find more from Nathalie: YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ  Join Nat's Membership Community: https://www.natniddam.com/bsp-community  Sign up for Nats Newsletter: https://landing.mailerlite.com/webforms/landing/i7d5m0  Instagram: https://www.instagram.com/nathalieniddam/  Website: www.NatNiddam.com    Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance  What We Discuss:  (00:06) Exploring Cancer Healing With Dr. Winters (10:51) Journey to Healing From Terminal Illness (23:44) Empowerment Through Genetic Repair and Lifestyle (30:22) Facing Cancer Fear With Psychedelic Healing (44:58) Ten Drivers of Cancer Healing (50:02) Cancer Healing Through Curiosity (01:02:39) Balancing Standard and Alternative Cancer Treatment (01:10:28) The Best of All Worlds Approach  

Free Guide - 3 Things You Need to Know About Cancer:  https://www.katiedeming.com/cancer-101/What role does our environment play in our healing process?Dr. Katie Deming was a guest on The Adult Chair podcast. She shared her journey from traditional oncology to integrative and conscious medicine. She discussed a holistic approach to cancer care that goes beyond conventional treatments.Key topics covered include:• The importance of diet, grounding, sunlight, and emotional work in fighting cancer• Aligning emotional, mental, and spiritual health to face illness• Practical tips for improving overall well-being, such as:  - Using blue blocker glasses  - Utilizing grounding pads• Managing emotions during treatment• The significance of a supportive environment• The power of mindful communication in healthcareThis isn't just for people affected by cancer but anyone looking for a more conscious approach to health and life. So, if you're interested in a fresh look at medicine that puts patient independence and holistic healing front and center, give this a listen.Listen to The Adult Chair podcast: https://theadultchair.com/podcasts/Join The Academy of Awakening membership for $1. Coupon Code HEAL: http://theacademyofawakening.com/Send us a Text Message.Don't Face Cancer Alone"The 6 Pillars of Healing Cancer" workshop series provides you valuable insights and strategies to support your healing journey - Click Here to Enroll MORE FROM KATIE DEMING M.D. Free Guide - 3 Things You Need to Know About Cancer: https://www.katiedeming.com/cancer-101/6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollWork with Dr. Katie: www.katiedeming.comFollow Dr. Katie Deming on Instagram: The.Conscious.Oncologist Take a Deeper Dive into Your Healing Journey: Dr. Katie Deming's Linkedin Here Please Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast DISCLAIMER:The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare provider.

Free Guide - 3 Things You Need to Know About Cancer:  https://www.katiedeming.com/cancer-101/Have you ever wondered if there's more to healing than medicine offers? Matty Lansdown from the How To Not Get Sick And Die podcast interviews Dr. Katie Deming, the Conscious Oncologist who blends Eastern wisdom with Western medicine to unlock natural healing potential. She questions conventional cancer treatments and explores intuition, emotional healing, and detoxification.Key topics discussed:What is a Conscious Oncologist?Dr. Deming's transformative experience that changed her approach to healingThe role of emotional healing in cancer careUsing intuition alongside medical data to guide patientsPractical methods for detoxification and immune system supportQuestioning if modern medicine addresses root causesTapping into inner wisdom for active participation in healingHow everyday habits may impact overall healthListen to Dr. Deming's holistic view of health, integrating physical, emotional and intuitive aspects of healing.Follow the How To Not Get Sick And Die podcast with Matty Lansdown: https://redcircle.com/shows/c3e57590-dd75-4201-8ee0-296df1ebae5bSend us a Text Message.Don't Face Cancer Alone"The 6 Pillars of Healing Cancer" workshop series provides you valuable insights and strategies to support your healing journey - Click Here to Enroll MORE FROM KATIE DEMING M.D. Free Guide - 3 Things You Need to Know About Cancer: https://www.katiedeming.com/cancer-101/6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollWork with Dr. Katie: www.katiedeming.comFollow Dr. Katie Deming on Instagram: The.Conscious.Oncologist Take a Deeper Dive into Your Healing Journey: Dr. Katie Deming's Linkedin Here Please Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast DISCLAIMER:The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare provider.

In this episode, Georgie is joined by the wonderful Carla Wrenn. Carla is a highly experienced Naturopath and was honored as the 2023 Australian Traditional Medicine Society Practitioner of the Year. With a Bachelor of Health Science in Naturopathy and multiple diplomas, Carla's expertise extends to Integrative Oncology, Autoimmune Diseases, and Functional Medicine. Carla is committed to providing exceptional care, especially in managing complex and chronic conditions. Carla and Georgie explore the anxiety that often accompanies chronic or complex health issues—especially when you're experiencing a wide range of symptoms, but all the tests are coming back negative. We'll even touch on the unsettling question: is it all in my head? Carla specifically shares: What to do when all your tests say you're "fine", but you're not fine What's the difference between a complex health issue and health anxiety? Understanding medical gaslighting Getting the most out of your supplement plan This episode dives into the realm of health anxiety and the challenges that come with it. Find out more about Carla's work: https://www.carlawrenn.com/ https://www.instagram.com/carlawrenn/ --------------------------------------------------------------------------------------- Need more anxiety support? Browse the Hypnotherapy Audio Library here: https://georgiecollinson.com/hypnosislibrary Watch my FREE Masterclass for women with high-functioning anxiety: https://anxiety-reset.mykajabi.com/free-masterclass Australia & NZ - order The Anxiety Reset Method book here: booktopia.kh4ffx.net/3Pbokn US & North America - order The Anxiety Reset Method book here: https://amzn.to/46OpjvH

Dr. Nasha Winters is an integrative oncology specialist, author of "The Metabolic Approach to Cancer” and “Mistletoe and the Emerging Future of Integrative Oncology,” host of the Metabolic Matters podcast, and Executive Director of the nonprofit organization, the Metabolic Terrain Institute of Health (MTIH).An internationally recognized authority in integrative cancer care and a sought-after public speaker, she champions a comprehensive approach to cancer treatment, combining standard of care with vetted metabolic and complementary therapies for optimal outcomes. She is a trusted consultant for medical professionals and researchers worldwide, offering expertise in patient evaluation and treatment strategies.You can find Dr. Nasha at:Dr Nasha Winters: www.drnasha.comMetabolic Terrain Institute of Health: www.mtih.orgMetabolic Matters Podcast: www.metabolicmatters.orgThe Metabolic Approach to Cancer: www.mtih.org/bookTo take the Terrain Ten questionnaire, go to: https://app.mtomics.comYou can find Dr Greg at:www.fitrxwellnessok.com

Whatever stage of your cancer journey you are on, Elemental Health Optimal Wellness & Counseling can help you live a healthier and more fulfilling life! More details at https://myelementalhealth.com/ Elemental Health Optimal Wellness Counseling, LLC City: Swannanoa Address: 10 Sunset Drive Website: https://myelementalhealth.com/ Phone: +1 9194396774 Email: contact@myelementalhealth.com

In this episode of the Dr. Jockers Functional Nutrition Podcast, Dr. David Jockers delves into our body's innate ability to heal itself, offering practical strategies for daily wellness. His conversation with Dr. Tony Jimenez adds depth, exploring non-toxic, integrative approaches to treating cancer and enhancing immune system function.   Dr. Jimenez shares insights into the complex nature of cancer cells and the critical role of the immune system in combating disease. His expertise in integrative oncology provides a compelling look at how small changes can significantly impact overall health.   Tune in for a powerful discussion on thriving through natural healing. Whether facing health challenges or aiming for peak wellness, this episode will equip you with the knowledge and motivation to take control of your health journey. Join us to learn how to harness your body's healing potential and achieve a vibrant, healthy life. In This Episode:   00:00 Introduction to Quality of Life Parameters   03:08 Introduction to Dr. Tony Jimenez 05:03 Dr. Tony Jimenez's Journey into Integrative Oncology 08:14 Understanding Telomeres and Their Impact on Health 12:34 Fasting and Its Benefits for Cancer Therapy 20:10 Seven Key Principles of Cancer Therapy 28:27 Research and Data Collection at Hope for Cancer 30:22 Understanding Cancer Cell Metabolism 31:04 Blood Sugar Levels in Cancer Patients 33:34 Inflammation and Cancer Progression 36:18 Blood Flow and Tumor Growth 39:55 Vitamin D and Cancer 44:16 Quality of Life in Cancer Treatment 47:41 Survival Rates and Integrative Approaches 50:35 Words of Inspiration and Hope 57:22 Conclusion and Final Thoughts   This podcast is sponsored by ShopC60.com. C60 is a powerful, Nobel Prize-winning antioxidant, that helps to optimize mitochondrial function, fights inflammation, and neutralizes toxic free radicals! I'm a big fan of using C60 in conjunction with your keto and intermittent fasting lifestyle to support your immune system, help your body detox, and increase energy and mental clarity. My favorite C60 products for Keto & IF lifestyles include C60 Purple Power in Organic MCT Coconut Oil (you can add this to your coffee) and their delicious Sugar-Free C60 Gummies (made with allulose and monk fruit)! If you are over the age of 40, and you'd like to kick fatigue and brain fog to the curb this year, visit shopc60.com and use the coupon code “JOCKERS” for 15% OFF  and start taking back control over your health today!   Have you heard of Paleovalley's amazing Turmeric Complex? It contains whole food and organic turmeric instead of just isolated curcumin.    And we know that organic turmeric is way better, and one of the best things you can take to shut down inflammation in the body and support healthy blood flow and blood pressure.    It also includes coconut oil and black pepper as its ingredients, which has been shown to improve the absorption of turmeric by 2000%! Plus, there's also organic ginger, rosemary, and cloves which synergize with the turmeric to help improve digestion and blood sugar.   Paleovalley's Turmeric Complex also supports joint health, mental clarity, and improved brain function. You've just got to try this product. Visit paleovalley.com/jockers!     “We need to stimulate the body's self-healing mechanisms; our body was wonderfully created to heal itself.” -Dr. Tony Jimenez     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean  TuneIn Radio   Resources: Visit https://shopc60.com/jockers – Use code “JOCKERS” to get 15% off! Paleovalley's Turmeric Complex - visit paleovalley.com/jockers     Connect with Dr. Tony Jimenez: Website - https://hope4cancer.com/ Book - https://amzn.to/4ctIaix   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/   If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/  

Dr. Wright is a Naturopathic doctor with 16 years' experience in the field of integrative oncology, having spent 12 years working in hospital-based oncology teams. Dr. Wright is passionate about helping patients access evidence based, natural therapies with a focus on improving quality and quantity of life. She provides tools to incorporate into each day, to create a body terrain that is in-hospitable to disease. Dr. Wright also shares pearls and proven strategies to help with recovery from surgery and to protect against the side effects of chemotherapy, radiation, immunotherapy and targeted therapy. Dr. Wright believes that empowering patients to best understand and participate in the decision-making for ongoing cancer treatment is an important part of care. Dr. Wright has special expertise in pancreatic cancer, breast cancer, ovarian cancer, brain cancers and digestive tract cancers, offering fundamental support for people with cancer or other chronic conditions. Dr. Wright sees clients via teleconsultation services and is not currently providing in- person care. Dr. Wright is the past president of the Oncology Association of Naturopathic Physicians (OncANP.org) and serves as Research Director for KNOWintegrativeoncology.org, a database of worldwide published human clinical trials in integrative oncology. Dr. Wright has published several articles that may serve as resources in your cancer care journey. Dr. Wright is licensed as a naturopathic physician by the state of Vermont. To connect with Dr. Wright, visit her practice, Good Apple Wellness at https://www.goodapplewellness.com KNOWintegrativeoncology.org, a database of worldwide published human clinical trials in integrative oncology - FaceBook -  Instagram  Oncology Association of Naturopathic Physicians (OncANP.org) - Facebook - Instagram _____ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here. To purchase the full 10-epidsode Docuseries visit Hay House Online Learning. Click Here, to learn more about health coaching with Liz or Karla.   Follow us on Social Media: Facebook , Instagram, YouTube.  

Dr. Karen Mustian joins us to share the latest update to the management of fatigue in adult survivors of cancer guideline from the American Society of Clinical Oncology and the Society for Integrative Oncology. Dr. Mustian highlights the recommendations across the continuum of care, including recommendations for patients with cancer-related fatigue during active treatment, after treatment, and for patients with advanced cancer or at the end of life. She also discusses interventions that are not recommended for treating cancer-related fatigue. The episode wraps up discussing the importance of this guideline for clinicians and patients, and a call for more research both on interventions and on dissemination and implementation to improve symptom management for cancer-related fatigue. Read the full guideline update, “Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update” at www.asco.org/survivorship-guidelines. TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/survivorship-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO.24.00541   Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.   My name is Brittany Harvey, and today I'm interviewing Dr. Karen Mustian from the University of Rochester School of Medicine and Wilmot Cancer Institute in New York, co-chair on “Management of Fatigue in Adult Survivors of Cancer: American Society of Clinical Oncology –Society for Integrative Oncology Guideline.” Thank you for being here, Dr. Mustian. Dr. Karen Mustian: Thank you for having me, Brittany. Brittany Harvey: Then, before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Mustian, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes.  So then, to dive into the content of this episode, Dr. Mustian, what is the purpose and scope of this updated guideline on fatigue in adult survivors of cancer? Dr. Karen Mustian: Cancer-related fatigue is one of the most common and debilitating consequences that patients experience when they go through treatment, and it can actually interfere with their ability to complete treatment and their recovery along the way. And it's not the same as a typical fatigue that you might experience from physical activity, let's say, where you can come back in and rest for a little while or take a nap or sleep, and you wake up refreshed and not feeling fatigued anymore. This type of fatigue actually needs special attention and needs to be treated with therapies.   So, this particular guideline is developed in a manner to help clinicians when patients present with fatigue, especially moderate to severe fatigue, that can be very debilitating, help patients decide what kinds of treatments they can use to reduce this fatigue. It's really important that this fatigue be reduced for a number of reasons. But some of the reasons we think of as being really critical are so that they can actually get their full treatment as prescribed, and then when finished with treatment, so they can actually resume their normal daily activities. They can keep working, they can keep engaging with their families, they can resume all those wonderful normal life activities that we hope for and that their prognosis will be a good one. Brittany Harvey: Absolutely. It's critical to address cancer-related fatigue for all adults with cancer.  Then, this guideline covers three distinct patient populations and provides recommendations for each. Starting with the first section, what are the key recommendations for patients with cancer-related fatigue during active treatment? Dr. Karen Mustian: Well, one of the things I want to mention about this guideline before I answer that question is this guideline encompasses the entire cancer trajectory. In previous guidelines for treating fatigue, we really focused on how to work with patients once they had completed their primary treatments for their cancer. This time, we're able, because the research and the literature have advanced more, to really now address what we should be doing to help patients with their fatigue while they're receiving active treatment. This can be primary treatment and/or maintenance therapies, but then also once they're done with treatment and they are in the recovery stage. And then also the third area is how should we help patients with advanced cancers with their fatigue that they are experiencing?  And I believe that you just asked me how we should be working with patients really during active treatment. This guideline, when we reviewed the literature, there's really good evidence to suggest that for people undergoing cancer treatment, clinicians should recommend exercise, cognitive-behavioral therapy, mindfulness-based programs, and Tai Chi or Qigong as first-line therapy to reduce the severity of fatigue that patients can experience during treatment. We also found that the literature suggests that psychoeducation and American ginseng may also be recommended in adults undergoing cancer treatment. Brittany Harvey: Understood. Thank you for providing those key recommendations for patients with cancer-related fatigue during active treatment.  Then, following those recommendations, at the next point in the cancer trajectory, what does the expert panel recommend for patients with cancer-related fatigue after treatment? Dr. Karen Mustian: Well, for survivors after treatment, the literature is also strong in that clinicians should be recommending also exercise, again, cognitive-behavioral therapy, and mindfulness-based interventions and programs. There's also a good amount of data to suggest that we should be recommending yoga, acupressure, and moxibustion for cancer-related fatigue after completion of treatment. Brittany Harvey: I appreciate you reviewing those recommendations as well.  Then that final third population that you previously mentioned, what are the key points for the management of cancer-related fatigue for patients with advanced cancer or at the end of life? Dr. Karen Mustian: For patients at the end of life, we should be offering those individuals cognitive-behavioral therapy and corticosteroids. Brittany Harvey: Thank you for reviewing all of those recommendations for patients with cancer-related fatigue during active treatment, after their treatment, and for patients with advanced cancer.  Are there additional recommendations that were made by the expert panel that we should know about treating cancer-related fatigue? Recommendations for things that we should not be doing to treat cancer-related fatigue? Dr. Karen Mustian: One of the things that's also characteristically different about this particular guideline update for ASCO is that this time we actually have research to suggest that there are some interventions that historically may have been used, but the research is actually suggesting that they should not be recommended at this time. The guidelines now state that clinicians should not recommend L-carnitine or antidepressants, wakefulness agents, or routinely recommend psychostimulants to manage symptoms of cancer-related fatigue. One of the things that this really highlights is the recommendation to pull back on the use of pharmaceutical products as a first-line therapy for treating fatigue and to really look at behavioral interventions which are showing the strongest evidence in the research in terms of effectiveness, both during treatment, after treatment, and for our patients with advanced cancer, and to really promote these behavioral interventions for patients rather than just reaching right for that pharmaceutical product.  There are still instances where pharmaceuticals may be really important for patients, such as if someone tries behavioral therapies and they fail, for example, or if someone has fatigue that is just absolutely so severe that they cannot even give a good effort or attempt to trying something like exercise or cognitive-behavioral therapy or mindfulness-based programs. You know, even considering that most of the cognitive-behavioral therapy and mindfulness-based programs don't require physical activity, they're very low intensity types of behavior change. And that's really a big area where these guidelines also differ in the update from previous guidelines.  Brittany Harvey: Absolutely. I appreciate you reviewing those so that we know what strategies and treatments also should not be used and how we need to tailor our interventions to specific patients and their needs.  So then, in your view, Dr. Mustian, what is the importance of this guideline and how will it impact both clinicians and patients with cancer-related fatigue? Dr. Karen Mustian: I've seen a lot of ASCO guidelines and helped with a lot of ASCO guidelines, and one of the things that I think is really great about this particular guideline for cancer-related fatigue is, I'll reiterate, this is one of the most prevalent, debilitating toxicities experienced by virtually all cancer patients at some point during their time being treated or in recovery. And I'm really pleased to see that the research has come far enough that we now actually have interventions that we can recommend strongly, and then we also have other interventions that we recommend that the evidence is still growing for.  What's also nice about this, and what's really going to be impactful for patients, as I just said, is that the recommendations are not focused on pharmaceuticals. Patients already take a lot of pharmaceutical products, we have to worry about polypharmacy and all the side effects associated with that, especially in our elderly populations. This guideline gives clinicians and patients not just one or two, but several behavioral interventions that they can use that, if used in the correct way, as stated in the guidelines, stand an excellent chance of reducing the amount of fatigue that they experience. So, it really is going to change the landscape of care for patients. It's also going to change the landscape of what clinicians have to offer in their toolkit for treating patients. And I know that oftentimes we think it's easy for a physician to recommend a pharmaceutical product. But I also know that a lot of oncologists love being able to recommend lifestyle interventions to really help their patients with side effects and toxicities. And that's exactly what this guideline is offering. And I think it's just going to provide a wonderful place for a clinician and patients to come together to have conversations about what the guidelines say is effective, and to allow them to have a conversation surrounding choice. Which one seems to be the best fit? Which one would a patient actually like to try? Which of these lifestyle interventions does the patient think they have the best chance of succeeding with both in terms of accessing it in their community, adhering to it, being able to do it so that they can actually derive the benefits that we expect to see. That's really one of the key components of the efficacy of these interventions as well, is what really is going to determine, ultimately, how well these interventions work is working together to pick the one that the patient feels that they can actually do and accomplish in order to receive the benefits. It really is going to change the landscape of how we work with symptom management surrounding fatigue. Brittany Harvey: Yes. As you mentioned, it's great to have these multiple evidence-based recommendations to have a real impact for patients. You also just noted that evidence is still growing in some areas. So what future research is needed regarding the management of cancer-related fatigue in adult survivors of cancer?  Dr. Karen Mustian: I think oftentimes when we see a guideline come out, many times people say, “Well, we have the answers now, so we don't need to fund any more research in that area.” Or maybe it becomes less of a priority. For all that we do have these treatments to recommend now, we're still really very in the early stages of being able to identify, characterize and accurately provide therapies and treatments for cancer-related fatigue. When I look back at the history of nausea and vomiting and where we've come in the decades of research that has ensued since the first initial findings on that. I think fatigue is still very much in its early years.   Some of the things that we still don't necessarily know when it comes to these kinds of interventions, and I can tell you we struggled with in the guideline committee, is what is the actual dose of some of these behavioral interventions? I think when we prescribe a medicine, we think, “Oh, you need this particular dosage of this particular agent. You take it this many times a day, this many times a week for x number of weeks, and there you go.” With behavioral interventions, it's a little more complex. And so really getting down to the nitty-gritty of defining exactly what type of exercise, the intensity of that exercise, exactly how many minutes a day, exactly how many minutes a week do you have to do? We weren't really able to get our recommendations refined to that degree, and I think future research that really wants to be in service of clinicians and patients should work towards defining specific prescriptions of these interventions.   Exercise, I just gave that example, but it's the similar kind of approach for cognitive-behavioral therapy. What are the specific components that need to be included? What does the ratio of focus on those different components need to look like? Also, the same with Tai Chi, Qigong moxibustion, acupressure that we mentioned - really refining those specific prescriptions, I think, is something that we need research on, and that will take us to the next step, where we have patients doing enough that they get the effect that they want, but not wasting their time, effort, energy, and finances doing too much that they don't need to do in order to achieve the benefit that we hope for.   For some of the recommendations that are not strong, we still need large, definitive, randomized clinical trials on those interventions. So, for example, we talk about that we may recommend psychoeducation and American Ginseng for patients undergoing cancer treatment. We need more research in that area in order to be able to really say whether or not we should be offering that for patients undergoing treatment. And specifically, those large, definitive, phase III randomized clinical trials, talking about trials that also could be done across multiple centers where we can have more generalizable populations, different kinds of communities where those interventions are being delivered, rural dwelling communities, for example. And then, of course, there's always the need for newer and better interventions. Some of these interventions have very decent effect sizes in terms of their outcome, but it would be wonderful to actually find an intervention that completely mitigated cancer-related fatigue, and it was completely gone, never to return. I think we're still in some ways waiting for that intervention to be developed. And I also would say, even though we're not recommending pharmaceuticals quite a lot in this guideline, they're not our first-line therapy, there's still always the opportunity to identify molecular targets that really could help with remediating cancer-related fatigue. So there's still a plethora of research to be done out there and things that we don't know.   And then lastly, and very much importantly, we need to do research and dissemination and implementation. Behavioral interventions are really challenging to deliver. So unlike a doctor recommending a pharmaceutical product where they can write a prescription, and then the patient gets the prescription from the pharmacy and they have what they need, supposedly understanding how to prescribe these interventions for patients, or even understanding how to refer them to places in communities where they can actually get a credible practitioner that is using an evidence-based approach that is known for being one of the types of yoga or exercise, or mindfulness-based stress reduction or CBT, that will actually have a positive influence on fatigue is also challenging. And so we need that dissemination and implementation research  - that I do believe is going to be also really key in the next decade at changing the landscape of what this toxicity looks like in the patient experience of cancer. Brittany Harvey: Definitely, these all will be key to understanding the best options for all patients, and we'll look forward to continued research in these areas to fuel future guideline updates and improve management of cancer-related fatigue in all adults with cancer.  So, I want to thank you so much for your work developing this guideline, and thank you for your time today, Dr. Mustian. Dr. Karen Mustian: Oh, it's such a pleasure. I did not develop this guideline alone. I definitely want to say thank you to all my colleagues who worked very diligently and very hard on digesting the research and making these recommendations. They are representative from institutions all across the United States. A very wonderful expert panel. Thank all of them very much and give them the credit that they are due for all their hard work. And thank ASCO for supporting these efforts for clinicians and patients. And Brittany, thank you very much for having me. Brittany Harvey: Absolutely. A big thank you to the whole panel.   And thank you also to all of our listeners for tuning into the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/survivorship-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    

A huge thank you to our partners Oxford Hormone Clinic for helping us get this episode out to all of you! Their support means so much to us. All their details are in the show notes below. Ever wondered if collagen is safe for you? There is a lot of talk about collagen out there and some people say it really helps them with their skin, joints and even energy levels. And then we hear stories of concern as collagen has been linked to cancer. In today's episode, I am joined by Dr. Nina Fuller Shavel to answer this once and for all. So that we know the facts to make empowered choices for ourselves.You can find Dr. Fuller-Shavel here https://www.drninafullershavel.com/Her new book “Integrative Oncology in Breast Cancer Care' can be found HERE.Download your FREE Getting Started Guide here: https://menopauseandcancer.org/getting-started-guide/Episode highlights:00:00 Intro04:53 Collagen benefits for joint and skin health.08:04 Long-term safety unknown; worth trialling cautiously.10:08 Vegan supplements may support collagen, but unproven.16:06 Dietary amino acids impact collagen production differently.17:11 Taking collagen during cancer treatment, consult your doctor.24:42 Diverse toolkit for joint health including Rosehip.27:41 Empowerment comes from variety.Thank you to our sponsors of this episode: https://www.oxfordhormoneclinic.com/The team at The Oxford Hormone Clinic are passionate in helping people with a history of cancer. They are a holistic clinic focusing on informed choice regarding all aspects of menopause care; from lifestyle advice, over the counter supplements, to Body Identical Hormone replacement, always based upon British Menopause Society (BMS) and NICE guidelines.About Dani:The Menopause and Cancer Podcast is hosted by Dani Binnington, menopause guide, patients advocate for people in menopause after a cancer diagnosis, and founder of the online platform Healthy Whole Me. There is lots of information out there about the menopause but hardly any if you have had a cancer diagnosis as well. Many people say to me they have no idea what their options are, who to ask for help, and that they feel really isolated in their experiences. I started this podcast because there was nothing out there when I was thrown into surgical menopause at the age of 39, which followed on from my cancer diagnosis aged 33.Through the episodes, I want to create more awareness, share information from our fabulous guest experts, doctors and other specialists in the cancer and menopause field. And of course, I will share stories from the people in our community.So that together we can work towards a better menopause experience. For all of us.More educated, better informed and less alone.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group:

Dr. Nathan Goodyear is on a bold mission to do the impossible: teach his patients' bodies how to heal all types of cancers through integrative oncology therapies. He's a brilliant integrative and naturopathic oncologist, a Fellow in Functional and Regenerative Medicine, a medical Advisor for NEO7 Bioscience, a Medical consultant with PICOIV (an innovative intravenous cannabinoid company), co-owner and medical product developer for Sanare-Pro, the President of the North American Society of Laser Therapy Applications (NASLTA)—and still has time to help his patients boldly do the impossible with integrative oncology therapies.  If you want to be filled with hope instead of fear and discover how to “stack therapies” that offer true healing, then this is an episode you may want to hear a few times. Tune in, take notes, and write hope into your future. 

Carla Wrenn, naturopath and educator, provides us with her insights into the important role the integrative practitioner may play in holistically supporting the oncology patient in our latest podcast. Having worked with our ambassador, Dr. Michelle Woolhouse in a collaborative care model to support cancer patients, Carla describes how she supports the cancer patient to obtain their best overall health, to reduce potential side effects of cancer treatment and to minimise modifiable risk factors to improve their health outcomes. Carla explains the complexity of the challenges faced by the cancer patient and how she supports them through diet, lifestyle and supplementation. Carla discusses the benefits herbs and supplements may offer for addressing inflammation, hormonal and blood glucose imbalances and stress while expressing caution on their use and discussing the hallmarks of cancer and the all important safety aspects of prescribing natural medicine for the cancer patient. Find today's transcript and show notes here: https://www.fxmedicine.com.au/podcast/replay-integrative-oncology-supporting-patient-holistically-dr-michelle-woolhouse-and-0 Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: https://pages.blackmores.com.au/FXM-signup.html ***DISCLAIMER: The information provided on fx Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.***

View the Show Notes For This Episode Dr. Nalini Chilkov discusses An Integrative Approach to Cancer at the Functional Medicine Discussion Group meeting on March 28, 2024 with moderator Dr. Ben Weitz.   [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]    Podcast Highlights   Dr. Nalini Chilkov is the founder of the American Institute of Integrative Oncology Research and Education and the creator of the The OutSmart ® Cancer System.  She is committed to training front line clinicians worldwide to become skilled and confident in serving the health needs of patients whose lives have been touched by cancer by utilizing her OutSmart Cancer® System. She is the author of the best seller, 32 Ways to Outsmart Cancer_How to Create A Body Where Cancer Cannot Thrive and is recognized as an authority and pioneer in the fields of Integrative Cancer Care, Cancer Prevention and Immune Enhancement. Dr. Chilkov has lectured worldwide and at the Schools of Medicine at UCLA and UC Irvine and is a frequent expert resource to the media.  Her websites are Nalinichilkov.com and the American Institute of Integrative Oncology. Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111. Dr. Weitz is also available for video or phone consultations.

In today's podcast episode, Dr. Steve Rallis (The Wellness Doctor) joins me to talk about how stress and insulin can potentially affect a person's health during the cancering process.Dr.  Rallis sheds light on the crucial role of fasting insulin levels in cancer management, revealing how personalized nutrition plans and stress management strategies can influence metabolic health and overall well-being. Dive deep into the world of integrative oncology, where the intersection of plant medicine, emotional resilience, and individualized care offers hope and empowerment on the journey to healing. Tune in for expert insights, practical tips, and a holistic perspective that will inspire and empower listeners to take charge of their health and embrace a path of transformation.Learn More  About Dr. Steve Rallis on His Website:https://www.wellnessdoctor.ca/ Suggested Resources:The Wellness Doctor on Instagram Nutrition GenomeDr. Rallis' YouTube PageThe Wellness Doctor on FacebookThe Wellness Doctor BlogLINK:  I Have Cancer, Now What? (Believe Big video series)Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now!

Megan S. Smith holds an M.S. in biology with a thesis in molecular genetics, and currently works as a documentary filmmaker and freelance investigative journalist in the areas of science and health. She produced and directed her first short documentary, “bOObs: The War on Women's Breasts,” which garnered international film festival awards. Starting October 2020, Smith's feature film by the same name was distributed by Los Angeles-based Cinema Libre Studio. The film looks into different breast cancer screening tests for women.In this episode, we discuss her newest film: “A New Standard of Care: Alternative Cancer Therapies,” which investigates the area of non-conventional cancer therapies. You can find the film and more about Megan at:www.anewstandardofcare.com orwww.boobsdoc.com

I had the pleasure of meeting and listening to Sean T. Devlin, DO, H.M.D. at the Annie Appleseed Project and Best Answers for Cancer conferences. Dr. Devlin is an expert in both Integrative Medicine and Integrative Oncology. The first time I met him during the events, I did not know he was a speaker. He […]

Cancer is a tremendous topic. Dr Julianna Giles, ND, has focused her career on evidence-based approaches for this complex condition. Dr Giles now directs our Integrative Oncology program at Neuroveda Health in Seattle, Washington. In this podcast, she walks us through cancer, soup to nuts. This includes defining cancer, describing different types and stages of cancer, and the conventional treatments of surgery, radiation chemotherapy and now immunotherapy. Dr Giles then layers in integrative approaches including high-dose (aka ‘pro-oxidant') IV vitamin C, other botanicals, metabolic approaches to treating cancer and the relationship between other immune dysfunction, like auto-immune disease or chronic viral infections, to cancer development. Next is a review of the core elements of our program, including specialty liquid biopsy testing, the timing necessary for balancing pro-oxidation (chemo) with anti-oxidant (recovery) targets, and the value we place on collaboration with conventional oncologists and treatments. We welcome patients to our program at all stages of cancer status including those with a family history seeking prevention, monitoring for early detection (we do pap/ HPV testing in clinic), treatment at all stages (early, middle, late), post-chemo/radiation recovery, prevention of recurrence and palliative care/ hospice as it's needed. Listen in and please share widely with those who are being affected by cancer. This is a critical show for broadening ideas about treatment options and maintaining agency at a time when health stress can be overwhelming. We discuss: ·     3:20 What is cancer? ·     6:36: How do we think and name different types of cancer? ·     9:09 Ayurvedic perspective of cancer ·     11:25 How does conventional care typically treat cancer? Surgery, radiation, chemotherapy ·     17:12 High dose IV (intravenous) vitamin C to make chemotherapy more tolerant to the body and prevent recurrences. ·     25:00 Fasting and chemotherapy treatment ·     28:35 Discussion about immunotherapy and metronomic (aka low dose) chemotherapy ·     32:12 Defining Integrative Oncology including the value of collaboration to help conventional treatments to work better ·     33:34 Looking at the foundations of health: asking and answering the ‘why' and ‘why now' questions ·     35:33 Molecular targets of botanicals, for example, p53 targeted by no drugs but impacted by curcumin; ·     36:55: Use of botanicals, diet and lifestyle as anti-inflammatory influences during pro-oxidant treatments like chemo- it's all about timing! ·    42:33 Discussion of the Integrative Oncology program at Neuroveda Health ·     56:30 Liquid biopsies looking for cell free mutated DNA shedding from cancers in the body ·     1:03:33: Putting together integrative treatment plans including the metabolic approach to cancer treatment ( Care Oncology protocol out of the UK) ·     1:08: How cancer interacts with the rest of the immune system, including auto-immune disease ·     1:12:38 Recovery after cancer treatment Bio: Julianna Giles is a Naturopathic Physician with a Masters in Ayurveda who specializes in integrative oncology, endocrinology, chronic infections, medical cannabis, entheogens and psychoneuroimmunology. After graduation from Bastyr University, she completed four years of residency training in integrative oncology. She is a core lecturer for the Academy of Cannabis Science and lead formulator for Polite and Lumna, both medical cannabis companies. While at the University of Wisconsin, Madison, she researched medicinal mushrooms and medical cannabis as adjunctive cancer therapies, as well as the neurological effects of mindfulness at the Wisconsin Institute for Sleep & Consciousness. Dr Giles is certified in Ayurveda Yoga therapy, Prana Flow and Kundalini Yoga. In her free time, she practices Yoga, is passionate about plant-based cooking, and loves exploring the wild Pacific Northwest.

On this show, Karolyn talks with integrative oncologist Mary Hardy, MD, about innovative ways to enhance the immune system. She'll discuss two ingredients in particular that have been researched extensively and shown to enhance immunity and mitochondrial function. Dr. Hardy is the former medical director of the UCLA Center for Integrative Oncology and is considered a leading expert on integrative cancer treatment and botanical medicine.Five To Thrive Live is broadcast live Tuesdays at 7PM ET.Five To Thrive Live Radio Show is broadcast on W4CS Radio – The Cancer Support Network (www.w4cs.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com).Five To Thrive Live Podcast is also available on Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

Integrative oncology provides data-driven therapies to help with pain, insomnia, anxiety and other side effects from cancer treatment. Medical oncologist, Santosh Rao, MD, explains how managing these symptoms can not only relieve side effects, but also improve treatment and outcomes.

Today on the pod we talk about cancer survivorship with Sanna Ali, MSN, CRNP, an Oncology nurse practitioner (NP), cancer survivorship researcher and advocate, and PhD student at the School of Nursing at George Washington University. She currently practices at the GW Center for Integrative Medicine. In her role as an NP, she saw first-hand the multifaceted, complex issues that burden cancer survivors. She decided to pursue her PhD to develop the research skills needed for knowledge generation and scientific discovery that will improve the quality of life and outcomes for cancer survivors. She has presented her PhD-related work both locally and nationally. She received a Sigma Theta Tau International, Phi Epsilon Chapter Small Grant for 2023-2024 to support her project, “Perspectives and attitudes of oncology professionals related to cancer survivorship: A qualitative case study.” NP Ali is the Maryland State Liaison for the American Association of Nurse Practitioners (AANP) where she works to advance and support the NP profession at the state and national levels. She is also a member of the National Coalition for Cancer Survivorship (NCCS) Champions program for clinicians and researchers interested in improving care for cancer survivors. ◘ Related Links NP Ali's bio https://bit.ly/48UcGPz National Coalition for Cancer Survivorship article on NP Ali https://bit.ly/497OI3u National Coalition for Cancer Survivorship https://bit.ly/3TFSP22 The National Cancer Institute's Office of Cancer Complementary and Alternative Medicine https://cam.cancer.gov/ American Society of Clinical Oncology's Integrative Oncology blog posts https://bit.ly/4913b15 ◘ Transcript https://bit.ly/3JoA2mz ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

What's the True Power of a Holistic Healing Approach?In our previous episode, we peeled back the layers of Dr. Katie Deming's life, revealing a series of deeply personal trials, from a profound shared death experience to the resilience found in solitude and reflection.Now, we turn the page to the next chapter, where Dr. Deming, armed with her own experiences and scientific acumen, embarks on a mission to bridge the worlds of Western medicine and holistic healing.Aiming to do more than just treat the disease, we take a deep dive into the essence of Dr. Deming's integrative oncology practice. Her vision extends beyond the immediate, tackling the emotional and spiritual upheavals that often accompany recovery.Chapters:02:42 - Creating a Holistic Approach to Medical Practice08:31 - Finding Clarity and Embracing Change11:07 - Opening to Feminine Energy13:13 - A Holistic Approach to Healing24:50 - The Impact of Informed Consent on Patient Healing31:32 - Demystifying Quantum Physics with Simple ExplanationsYou'll be privy to her unique role as a compassionate guide for those battling illness, empowering her patients to make informed, confident decisions about their health.And as we explore her career's evolution and the rebirth of her podcast, we'll also enter the enigmatic realms of quantum physics and the convergence of spirituality and science.Whether you're seeking solace in the face of cancer, supporting a loved one, or simply desiring a life of greater wellness, this episode is a treasure trove of wisdom. Join us on this intimate exploration of Dr. Katie Deming's journey of transformation and healing, and perhaps, find the inspiration to embark on your own.Press play, and let the journey to healing begin. MORE FROM KATIE DEMING M.D. Take a Deeper Dive into Your Healing JourneyFollow Dr. Katie Deming's Substack HereWork with Dr. Katie:www.katiedeming.comFollow Dr. Katie Deming on Instagram:The.Conscious.OncologistPlease Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast

Are you ready to delve into the future of cancer care?  Dr. Nasha Winters, ND, a renowned naturopathic doctor and Fellow of the American Board of Naturopathic Oncology, is at the forefront of research and clinical application of mistletoe therapy for cancer.  We unlock the secrets of this well-studied and promising therapy, including its administration, and the groundbreaking book "Mistletoe and the Emerging Future of Integrative Oncology." Gain valuable insights into the accessibility, affordability, and powerful role of lifestyle choices in integrative cancer care.   We talk about: 19:30 - From patient to biohacker: Dr. Nasha's journey towards holistic health 25:00 - How to start with integrative cancer care 31:00 - Biohacking is not only for the wealthy 43:45 - Mistletoe therapy: an effective, underutilized cancer treatment 48:10 - The book: Mistletoe and the Emerging Future of Integrative Oncology 51:00 - Overcoming pushback and educating patients on mistletoe therapy 54:00 - Creating a comprehensive metabolic oncology hospital and research institute 59:30 - You don't have to heal alone   Sponsors: Get Bahé grounding shoes to reconnect you with earth! Use my code BIOHACKINGBRITTANY to save 10% now. Get Bioptimizers supplements digestive enzymes, probiotics and magnesium. Use discount code BIOHACKINGBRITTANY for the largest discount possible.    Resources: Get $100 OFF(!) my new preconception health course by joining my waitlist today. Only those on the waitlist will have access to this limited-time offer.   Try my Hormone Balancing Chocolate recipe! It's delicious and your body and hormones will thank you. My Amazon storefront Dr. Nasha Winter's website and mtih.org   Let's Connect: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, Google Podcasts

Dr. Nasha Winters dives deeper into her written works, discussing her two books, The Metabolic Approach to Cancer and Mistletoe and the Emerging Future of Integrative Oncology co-written with Dr. Steven Johnson, DO.   For more information on her books and to order them, visit https://www.drnasha.com/matcbook/.     ************** To learn more about Dr. Goodyear, visit his website at drgoodyear.com.  For more interesting videos on a variety of topics, TikTok videos are updated daily at www.tiktok.com/@briomedical and long-form videos can be found on our YouTube Channel www.youtube.com/@BrioMedical. Patients interested in pursuing their cancer healing journey can visit Dr. Goodyear at Brio Medical in Scottsdale, Arizona by visiting brio-medical.com.

Looking for a naturopathic approach to cancer? In this episode of The Dr. Kinney Show, I sat down with Dr. Sonia Malani, who is a naturopathic doctor who specializes in cancer care, to have a conversation all about integrative oncology and the options you have as a cancer patient.Dr. Sonia Malani ND, FABNO is a physician, author, and researcher. Dr. Malani graduated from Bastyr University with her doctorate in naturopathic medicine, and I am so excited to share this fascinating conversation with you. Topics covered in this episode include:The role of an integrative oncologistThe improved quality of life integrative oncologists offerThe role of insulin in cancerWhy more people than ever want to learn about naturopathic medicineHow cancer can change your lifeThere is so much that can be done for cancer patients, and integrative oncologists can be a huge part of your healing journey. Tune in to learn how! Show notes available at www.drerinkinney.com/141Resources Mentioned: Follow Dr. Malani on Instagram: https://www.instagram.com/drsoniamalani/?hl=enVisit her website: https://drmalani.com/Check her out on Rupa Health: https://www.rupahealth.com/author/dr-sonia-malaniVisit the OncANP website: https://www.oncanp.org/find-an-nd#!directory/mapI would love to connect on Facebook: https://www.facebook.com/DrKinneyND and Instagram: https://www.instagram.com/drkinney!

#430: Laura Vasquez, MSN, APRN NP-C, is a Family Medicine Board Certified Nurse Practitioner through the American Academy of Nurse Practitioners who is also certified in the Metabolic Approach to Cancer. Her focus is on Integrative Oncology and other complex conditions, and she works out of the riordan clinic, an integrative healthcare facility in overland park, ks She provides support to patients in all phases of their treatment. Over the years, her passion for integrative health has continually grown as she sees the value of natural therapies in the changing landscape of modern medicine. Discussed: In-depth lab testing and treatments such as targeted supplementation, dietary modifications, and IV nutrient therapy; the metabolic approach to cancer, the ketogenic diet, underlying contributors like inflammation, infections, and environmental toxins, intermittent fasting, Ozone, Mistletoe and more! https://riordanclinic.org/staff/laura-vasquez-msn-aprn-np-c/   Find Liz on Instagram: @realfoodliz Real Food Liz Eat The Yolks Baby Making and Beyond Athletic Mom Thanks for listening!